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CHAPTER I 
INTRODUCTION 
Elastin is one of the major connective tissue proteins and is pre-
sent in virtually every organ of the body. It is unique in that it is a 
protein with both elasticity and tensile strength. Elastin is found in 
both "yellow" and "white .. connective tissue (tissue with a high content 
of elastin is designated as yellow, while tissue with a high content of 
collagen is designated as white). It is the functional protein component 
of the elastic fiber and displays an amorphous, highly refractive, gener-
ally wavy appearance under light microscopy. Upon stretching of the elas-
tic fibers, the waviness disappears and increased birefringence is dis-
played. These properties are attributed to a parallel arrangement of the 
elastin polypeptide chains within the elastic fiber upon stretching 1. 
Specific stains for elastin have long been in use in light micros-
copy. Classic stains for elastin are Verhoeff's hematoxylin, resorcin-
fuchsin, and orcein 1' 2. Other stains used to visualize elastic fibers 
include Nile blue sulfate, basic fuchsin, osmic acid, Sudan black, and 
Mallory's aniline blue stain, which distinguishes between elastin and 
collagen 3' 4. Electron microscopy stains, such as uranyl acetate and 
lead citrate, allow the visualization of the surrounding microfibrillar 
component, while elastin itself remains mostly unstained 1. Thus, the 
ability of mature elastic tissue to take up light microscopy stains re-
sides either in the presence of unreacted aldehydic groups within the 
elastic matrix or in the strong hydrophobic nature of the protein S,fi 
1 
2 
From microscopy and biochemical studies, it has been determined that 
elastic tissue is comprised of water (approximately 70%), a microfibril-
lar protein component, lipids, carbohydrates, and the protein elastin 7' 8. 
It has been observed that elastin can be found wherever elasticity and 
tensile strength are required, primarily in structures which display high 
deformation under small loads and complete recovery after removal of that 
load. Therefore, elastin is in great abundance in the ligamentum nuchae 
of ungulates, the vertebral ligamenta flava, aorta, lung, and pulmonary 
arteries of all primates 1. Specialized forms of elastic tissue include 
elastic cartilaginous tissue, such as the ear and epiglottis. Bronchi, 
skin, adipose tissue, and loose connective tissues are included as elas-
tic tissue even though low in elastin content 1 (Table 1). 
A unique property of elastin is its almost complete resistance to 
methods normally used to solubilize other proteins. This was first ob-
served by Richard and Gies who subjected elastin to boiling water which 
served to gelatinize and remove collagen 9 These investigators noted 
elastin's resistance to alkali degradation and its non-polar nature, 
which was attributed to a high carbon to oxygen ratio. Finally, they 
demonstrated that elastin peptides aggregated upon heating. This coacer-
vation, which represents a form of precipitation, is believed due to a 
high content of non-polar amino acids in the elastin molecule. 
Using x-ray diffraction studies, Lloyd and Garrod observed struc-
tural similarities between elastin and lightly vulcanized rubber in that 
both lack molecular orientation 10 . It was determined that elastin is 
not a true rubber since it requires water as a lubricant. Elastin con-
sists of randomly coiled polymer chains which are joined together by 
TABLE 1 
ELASTIN CONTENT OF CONNECTIVE TISSUES FROM DIFFERENT ANIMALS 
Species Aorta Lung Uterus Ear· Ligament 
Human 47.1 24.0 6.2 
Bovine 48.2 6.0 66.0 
Porcine 45.0 24.6 1.0 ' 
Dog 40.0 15.7 0.9 
Rat 40.6 13.4 1.5 
Chick 58.5 12.0 0.9 
Rabbit 17.4 6.0 0.8 4.0 
Guinea pig 25.0 4.2 
Hamster 22.0 2.4 
Elastin content is expressed as percentage of the salt-extracted, freeze-dried tissue. 
Whole lung excluding major pulmonary vessels and bronchi. 
From Starcher and Gallone (101) 
w 
4 
cross-links into an extensible three-dimensional network. The cross-
links are the derived amino acids, desmosine and isodesmosine, identified 
by Partridge and co-workers 11 , 12 These cross-links are responsible for 
the characteristic physical properties of the elastin molecule, i.e., its 
rubber-like elasticity and almost complete insolubility. 
The catabolic turnover rate of elastin is low relative to other pro-
teins. Therefore, changes in tissue content as well as structural compo-
sition of elastin is altered principally by de~ syntheses l, 13 . Per-
haps the most dramatic changes in elastic tissue and elastin have been 
observed in the arteries, lung~, and skin of various species with age. A 
11 brittleneSS 11 in these organs with age has also been observed. This ob-
servation may be related to elastin content 1,9,13, 15 ,18, 21,22 
Elastin has been implicated in several disease states (Table 2). 
It has been suggested that changes in elastin may play a role in alter-
ations which occur in blood vessels during degenerative arterial disease, 
as it is common to see alterations in the microscopic elastic network of 
these vessels during the disease state 1, 9, 13 • There is some evidence 
that certain pulmonary disorders, such as emphysema, may be associated 
with changes in the elastin content of the lung. 1,9,19 ,20 . Finally, 
elastin may be involved in certain hereditary skin diseases 1,9,23 
Thus it would be advantageous to know the amount and composition of 
elastin in normal conditions in order to understand the various patholog-
ical processes involved in the mentioned disease states. However, this 
information is lacking in that the major source of data pertaining to the 
amount of elastin is derived from gravimetric determinations on the 
residue remaining following the extraction of minced or milled samples. 
TABLE 2 
EFFECTS OF DISEASE ON ELASTIN AND RELATED FEATURES 
DISEASE 
ATHEROSCLEROSIS 
EMPHYSEMA 
PsEUDOXANTHOMA 
ELASTICUM 
HISTOLOGIC 
ABNORMALITY 
FRAGMENTED ARTERIAL ELAS-
TIC LAMELLAE WITH CALCIUM 
AND LIPID DEPOSITS AND IN-
TIMAL THICKENING. 
FRAGMENTED ELASTIC FIBERS 
PRESERVATION OF MICROFIBRILS 
DESPITE DESTRUCTION OF AMOR-
PHOUS ELASTIN, 
FRAGMENTED ELASTIC FIBERS 1 
GRANULAR DEPOSITS IN PLACE 
OF AMORPHOUS ELASTIN, 
FROM SANDBERG ET, AL, (1) 
FUNCTIONAL 
ABNORMALITY 
t VESSEL STIFFNESS 1 VASCULAR 
OCCLUSION AND TEARS, 
t COMPLIANCE OF THE LUNG AT 
LOW LUNG VOLUMES, 
t CoMPLIANCE OF SKIN AND 
FRAGILE VESSELS, 
U1 
TABLE 2 (CoN'T) 
EFFECTS OF DISEASE ON ELASTIN AND RELATED FEATURES 
DISEASE 
ATHEROSCLEROSIS 
EMPHYSEMA 
PsEUDOXANTHOMA 
E~ASTICUM 
BIOCHEMICAL 
ABNORMALITY 
+ELASTINJ +COLLAGEN CON-
TENT AND +CALCIUM AND 
LIPID CONTENT OF ELASTIN 
+POLAR AMINO ACID AND CROSS-
LINKS IN ELASTIN, 
EARLY +ELASTIN CONTENT AND 
+ELASTIN SYNTHESIS, LATE: 
+ELASTIN SYNTHESIS AND 
POSSIBLY +ELASTIN DEGRADA-
TION, LATER: NORMAL ELAS-
TIN CONTENT: +POLAR AMINO 
ACIDS OF ELASTIN AND POSSIBLY 
tPROTEOGLYCANS, 
PoLYIONIC DEPOSITS ON 
ELASTIC FIBERS, 
ETIOLOGIC 
DEFECT 
PossiBILITIEs: RESPONSE 
TO INJURY; MONOCLONAL ORIGIN 
OF PLAQUES; CLONAL SENESCENCE, 
POSSIBILITY: IMBALANCE BE-
TWEEN ELASTASE AND INHIBITOR 
SYSTEMSJ PERHAPS IN RESPONSE 
TO EXOGENOUS AGENTS OR GENETIC 
FACTORS, 
SPECULATION: POLYIONIC DE-
POSITS (POSSIBLY GLYCOPRO-
TEINS) ATTRACT CALCIUM AND 
CAUSE ELASTIN DAMAGE, 
0'\ 
The determinations are, at best, tedious and somewhat non-reproducible 
and subject to various problems including sample degradation 14 ,24-26. 
In the gravimetric procedures the extraction conditions are varied, and 
so are the results. These extractions include: 1) extraction with 1% 
sodium chloride followed by several cycles of autoclaving 14 ,27 ,28 ; 2) 
extraction with hot 0.1 mol/L sodium hydroxide 14 , 18 ,28- 31 ; 3) extrac-
tion with formic acid 14 , 32 , 33 ; and 4) extraction with 5 mol/L guanidine 
followed by treatment with collagenase 14 ,34 
A methodology for the study of elastin currently under development 
focuses on the two cross-linking amino acids, desmosine (Des) and iso-
desmosine (Ide). These amino acids have only been found in the protein 
elastin and in the non-elastin protein in egg shell membranes 35-38 . 
Thus, their quantitation may be used as an index of the elastin content 
of tissue, just as hydroxyproline is used as an index of the amount of 
collagen present in a tissue 39 ,49 . 
7 
Although various chromatographic methods have been developed for the 
purification and quantitation of Des and Ide 37 ,41-48 , few studies employ 
amino acid quantitation as an index of elastin content 39 , the chromato-
graphic procedures being tedious, cumbersome, and limited in their scope 
of application. The few studies utilizing the desmosines for the estima-
tion of elastin employed automated amino acid analysis, a technique which 
is both costly and time consuming. 
FUNCTIONAL ASPECTS OF ELASTIN 
Many of the physical properties of the elastin molecule resemble 
those of the rubber molecule 50 However, elastin is not believed to be 
8 
a largely random network of cross-linked chains~ like rubber. In contrast 
it is believed to be a network of cross-linked chains containing signifi-
cant ordered structure 51 Several models have been proposed to explain 
its functional aspects, as well as its high degree of organization 50- 56 . 
Partridge envisioned elastin as tetrahedrally packed, globular pro-
tein subunits, with the hydrophobic residues turned inward with the cross-
links protruding from the surface 50 . Using this model, Weis-Fogh and co-
workers suggested the functional properties occur by polar-apolar inter-
actions, as the hydrophobic core of the globular subunits are exposed to 
an aqueous environment upon stretching 52 • 
Another model~ the random chain, is supported by evidence suggesting 
that the elastin chains are in rapid Brownian motion 53 ,54 . This model 
is also supported by classical thermodynamic considerations 53 ,54 
A third model, the ••oiled-coil"~ has been suggested by Gray and co-
workers 55 They claim that the regions of the elastin molecule which 
contain the cross-links are separated by regions composed predominantly 
of glycine~ proline, and valine. They view these regions as a 11 broad 
left handed coil 11 with the hydrophobic residues on the inside and the hy-
drophilic residues on the outside. Upon extension of the molecule, the 
coil would be opened, which would expose the hydrophobic groups to a more 
polar environment. This configuration would be thermodynamically un-
favorable and the molecule would tend to return to its original state. 
A fourth coiled model is suggested from the observation that the 
repeating sequences in the elastin molecule predominantely represent a 
single secondary structural feature, the S-turn 56 
9 
COMPONENTS OF ELASTIN BIOSYNTHESIS 
The biosynthesis of elastin is a complex process that includes: syn-
thesis of a microfibrillar component by fibroblasts; synthesis of an 
elastin precursor, tropoelastin; and finally, the formation of the mature 
elastin fiber by the action of lysyl oxidase. 
Microfibril Component: 
The non-elastin component of the elastic fiber is the microfibril 13 . 
This glycoprotein component is referred to as a structural protein, but 
its exact function has not been determined 1. These fibers, which are 10 
to 20 nm in diameter, are synthesized by either the fibroblasts or the 
smooth muscle cells 49 , 57 , 58 . This protein lies adjacent to either the 
fibroblast or the smooth muscle cell (which also produce elastin) respon-
sible for its synthesis. The microfibrils are laid in bundles parallel to 
the long axis of the developing elastin fiber. These fibers may represent 
the first immature elastin fibers, and as the elastin matures, the micro-
fibrils are found in the interstices and around the periphery of the elas-
tin fiber. There has been some evidence that, in certain areas, these 
microfibrils display periodicity and take on a beaded appearance 1 
The amino acid content of the microfibrils is dissimilar to that of elas-
tin as evidenced by the presence of histidine, methionine, and cystine, 
and the lack of Des and Ide. Also, the non-polar to polar amino acid 
ratio differs from that of elastin 13 . The microfibrils have been shown 
to contain at least two glycoprotein constituents, designated MFP 1 and 
MFP 2 59 . MFP 1 is a collagenous glycoprotein of 150,00 daltons while 
10 
MFP 2 is a non-collagenous glycoprotein of 300,000 daltons 59 
Tropoelastin: 
Concomitant with the synthesis of the microfibrils is the synthes~s 
of tropoelastin, or soluble elastin 58 Tropoelastin is synthesized from 
the same fibroblasts or smooth muscle cells as the microfibrils, and was 
first isolated by Smith and co-workers from the aortas of copper-deficient 
swine 60 Since this discovery other native soluble elastin molecules 
have been isolated from the aorta of various species including copper-de-
ficient chicks 61 , lathyritic chicks 62 , 63 , and from the ligamentum nu-
chae of copper-deficient calves 64 . 
Tropoelastin is composed of a single polypeptide chain of approxi-
matly 800 residues (68,000-72,000 daltons) 65 ,66 . At present only 70% 
of the sequence is known, but it is clear that the majority of the resi-
dues are non-polar amino acids, such as glycine, proline, alanine, valine, 
phenylalanine, isoleucine, and leucine. The small number of polar amino 
acid residues, such as aspartic acid, glutamic acid, arginine, and lysine 
lend solubility to the molecule. 
The amino acid content of a tropoelastin preparation is given in 
Table 3. Tropoelastin usually contains little or no histidine. It also 
lacks methionine, and other sulfur-containing amino acids. Arginine is 
present in minimal amounts while the remainder of the molecule consists 
largely of apolar amino acids. For these reasons, the purity of tropo-
elastin is sometimes measured by the absence of histidine and methionine 
in protein hydrolysates 67 . Hydroxyproline, a major component of colla-
gen (40%), is found in relatively small amounts (5%) in the tropoelastin 
TABLE 3 
AMINO ACID COMPOSITION OF SOLUBLE AND MATURE 
<INSOLUBLE) ELASTIN FROM THE PIG 
SOLUBLE MATURE 
AMINO AciD ELASTIN ELASTIN 
GLYCINE 245 256 
ALANINE 187 181 
PROLINE 91 90 
HYDROXYPROLINE 7 8 
VALINE 103 92 
ISOLEUCINE 14 14 
LEUCINE 41 41 
TYROSINE 14 12 
PHENYLALANINE 24 25 
ARGININE 4 5 
LYSINE 37 5 
CROSS-LINKS* VERY LOW 25 
ASPARTIC ACID AND 3 5 
ASPARAGINE 
THREONINE 10 11 
SERINE 8 11 
GLUTAMIC ACID AND 12 16 GLUTAMINE 
METHIONINEJ CYSTEINEJ 0-1 1 TRYPTOPHAN AND 
HISTIDINE 
HUMAN ELASTIN HAS A SIMILAR COMPOSITION, 
BASED ON AN ASSUMED CHAIN LENGTH OF 800 RESIDUES, 
* - EXPRESSED AS LYSINE EQUIVALENTS, A NUMBER OF INTERMEDIATES ARE 
ALSO INCLUDED IN THIS ESTIMATE, ACTUAL LYSINE EQUIVALENTS IN 
DESMOSINE AND ISODESMOSINE ARE EIGHT TO 10, 
FROM SANDBERGJ ET, AL, (1) 
11 
12 
molecule. Other hydroxylated amino acids are not found in the tropoelas-
tin molecule 68 . 
All methods for the purification of the tropoelastin molecule are 
usually performed in the presence of proteolytic inhibitors 61 -63 ,67 ,69 . 
This is necessary due to the susceptibility of the tropoelastin molecule 
to cleavage by various proteases which are often associated with the sol-
uble elastin fractions 13 , 70 
Recently, there has been some discussion of the existence of a pre-
cursor of tropoelastin 71 , 72 . Rucker and co-workers have postulated that 
tropoelastin is derived from a soluble protein of approximately 95,000 
daltons 71 . These investigators used aortas from copper-deficient chicks 
and a1-antitrypsin at each step of purification. With this modification 
they were able to detect a pre-tropoelastin. Their conclusions were 
based on terminal amino group analysis of the molecule which they state 
is the same as tropoelastin. Also, the amino acid composition of the 
pretropoelastin is similar to that of tropoelastin. It contains a limit-
ed number of aldehydic functions and is a viable candidate for action by 
lysyl oxidase. The pre-tropoelastin was found in greater concentrations 
in the aortas from the copper-deficient chicks. 
Foster and co-workers have reported the isolation of a proelastin, 
120,000-130,000 daltons, from lathyritic chick aorta and second passage 
aortic smooth muscle cells from rabbits 72 . Using a pulse-chase tech-
nique, involving the incorporation of 3H-valine and 14c-proline, they ob-
served a high molecular weight soluble protein. When chased for a period 
of 30 minutes to 1 hour, its concentration decreased with the concomitant 
appearance of the 70,000 dalton tropoelastin. Direct identification of 
13 
the high molecular weight protein as a precursor to tropoelastin was pro-
vided by amino acid analysis. The amino acid composition of the high 
molecular weight peak was very similar to that of tropoelastin. Foster 
also reported finding a soluble protein of 90,000-100,000 daltons which 
had also been identified by Rucker 71 . This was added evidence of the 
existence of a pro-elastin molecule. 
These findings are controversial. Rosenbloom and co-workers found 
that the presumed pro-elastin contained considerable amounts of histidine 
while tropoelastin and elastin contained little, if any 73 . Rosenbloom 
used a hisitidine analog, histidinal, that would inhibit elastin biosyn-
thesis if pro-elastin were a precursor to elastin. They found that while 
collagen synthesis was markedly inhibited by histidinal, tropoelastin 
synthesis was relatively unaffected. By using pulse-chase experiments 
they observed that the labeled tropoelastin was efficiently incorpora-
ted into insoluble elastin both in the presence and absence of histi-
dinal. From these findings, Rosenbloom suggests that tropoelastin was 
the primary precursor in elastin biosynthesis in chick aorta. 
Lysyl Oxidase: 
Lysyl oxidase is the major enzyme responsible for the conversion of 
tropoelastin to mature elastin. This enzyme has been shown to catalyze 
the reaction of the peptidyl lysine residues in the tropoelastin molecule 
to lysinal. This reaction is necessary if the cross-links found in the 
mature elastin molecule are to occur. Lysyl oxidase has been detected in 
numerous connective tissues and smooth muscle cells in vitro. It has 
been shown to be involved in the oxidation of peptidyl lysine to lysinal 
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in both elastin and collagen biosynthesis 74 . The enzyme has been found 
in close association with its substrate, tropoelastin, and has an abso-
lute requirement of copper for maximal activity 7S- 78 . 
There is also evidence that the enzyme exists in various forms 98 . 
Two isozymes of S9,000 and 61,000 daltons, A and B respectively, have 
been isolated from bovine aorta 78 . It is unclear which form predomi-
nates ~vivo. Another lysyl oxidase of approximately 180,000 daltons 
has been isolated from bone although its function is not yet known 79 
BIOSYNTHESIS OF ELASTIN 
Three components of elastin biosynthesis (microfibrils, tropoelas-
tin, and lysyl oxidase) work in concert to form the mature elastin fiber. 
The general scheme is as follows: first, the fibroblasts or smooth muscle 
cells synthesize the microfibrils which are then deposited along the 
small infoldings on the surface of the cell sa. Second, perhaps concomi-
tant with the synthesis of the microfibrils, tropoelastin is synthesized 
intracelluarly on the ribsomes sa. Once tropoelastin is synthesized, it 
is transported outside the cell by an unknown mechanism sa. Here the en-
zyme lysyl oxidase oxidizes the E-amino groups of the lysine residues to 
aldehydes. These aldehydes condense, via Schiff base reaction, to form 
the cross-links in the elastin molecule sa. As the modified lysine resi-
dues condense, tropoelastin loses its solubility and aggregates around 
the microfibrils, possibly by electrostatic interaction between the two 
molecules, forming the mature elastin molecule 58 
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Mature Elastin: 
In its mature form, insoluble elastin is composed of 4 soluble elas-
tin subunits (tropoelastin) that are intermolecularly cross-linked into 
a fibrous network. Elastin, as in tropoelastin, maintains a predomin-
ance of non-polar amino acids, with less than 5% polar amino acids 
(Table 3). This predominance of non-polar amino acid residues seems 
unique to elastin and is, therefore, a good means of identification. 
One of the main differences between tropoelastin and elastin is the 
greater lysine content of the former (Table 3). While the tropoelastin 
molecule contains up to 40 lysine residues per 1000, the elastin molecule 
may contain only 3 to 8. This decrease in the amount of lysine is due 
to a direct conversion of lysine into cross-links. As a consequence of 
these cross-links, a highly polymerized and insoluble protein is pro-
duced 13 . 
Elastin is similar to collagen in that it contains large amounts of 
the amino acids glycine, valine, alanine, and proline. In fact, due to 
the large amount of valine and proline incorporated in the elastin mole-
cule, these amino acids, when labeled with a radioisotope, are used as 
an index of elastin biosynthesis 79 . Elastin contains approximately 10% 
as much hydroxyproline as collagen and contains no hydroxylysine. Elas-
tin and egg shell membrane protein are unique in that they are the only 
proteins so far analyzed found to contain Des and Ide , which account for 
approximately 1% by weight (Fig. 1). 
The amino acid composition of elastin has been shown to vary slight-
ly between tissues from the same species. A slight variation has also 
been observed in the same tissue from various species. In both cases, 
HOOC-:-<fH-(CHz)z 
NHz 
I 
CH2~-CH-COOH 
J ~Hz 
NHz · 
I 
CH2)3 -CH-COOH 
(CHz)4- CH-COOH I 
NHz 
ISODESMOSINE 
Fig. 1. Structure of desmosine and isodesmosine. 
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the variability lies mainly in the non-polar amino acids (Table 4). This 
variability may be due to the purification methods utilized 80 ,81 . 
Much of the elastin molecule appears to be comprised of repeating 
sequences in the form of tetra-, penta-, and hexa-peptide units 13 • For 
example, common tetra-, and penta-peptide sequences are Gly-Gly-Val-Pro 
and Pro-Gly-Val-Gly-Val, respectively. The repeating hexa-peptide unit 
common to elastin is Pro-Gly-Val-Gly-Val-Ala-. There also seems to exist 
a homology with respect to the N-terminal portion of the elastin molecule 
from unrelated species 61 ,62 . 
Another structural feature which seems common to the repeating se-
quences in the peptide chain is the beta turn 82 . With this beta turn 
present, the elastin chain is able to fold back on itself. These beta 
turns, when repeated several times, impart a unique structure to the 
elastin molecule, known as the beta spiral. This beta spiral is not 
known to occur in any other mammalian protein and may be important in the 
formation and function of the elastin fiber 1' 82 • 
One other feature which seems to set elastin apart from other pro-
teins is its alanine enrichment 1 In the tropoelastin molecule, lysine 
residues almost always occur in pairs, and it is in these regions where 
alanine enrichment seems to occur. That is, the lysine pairs are separa-
ted by anywhere from 1 to 3 alanine residues and can be preceded by as 
many as 8 alanine residues in the sequence 83 ,84 . It appears that the 
alanine enrichment is essential for the cross-linking of the lysine re-
sidues in the molecule 1. 
From studies on these restricted areas of alanine enrichment, it has 
been proposed that a specialized structure exists in the cross-link areas, 
TABLE 4 
ARTERIAL ELASTIN - COMPOSITION OF INSOLUBLE AORTA ELASTINS 
·- -- --· . ··- --· - ·--
-----·-----
CQW ~ 
AMINO ACID PIG C~ll c K DoG RABBIT AoRTA [I GAMEI'HUM 
GLY 330 340 335 321 311 332 282 281 
ALA 234 180 228 227 223 228 220 232 
VAL 120 177 97 101 137 138 129 126 
PRo 117 131 119 125 132 117 118 112 
HYPRO 11 16 13 16 13 16 11 15 
ILE 18 20 28 22 27 25 27 27 
LEu 54 57 49 58 65 60 62 60 
TRY 16 13 28 28 8 6 25 23 
PHE 33 21 27 22 33 29 25 25 
THR 14 22 15 12 9 10 17 18 
SER 11 13 16 7 9 10 14 16 
AsP + AsN 6 6 8 15 7 8 11 16 
GLU + GLN 19 19 19 14 16 16 23 30 
MET* (2) (2) 
His* <1 2 2 <1 <1 <1 2 4 
ARG 6 8 10 3 6 5 11 14 
LYs 6 4 4 7 5 3 6 10 
IDE 1.2 1.0 0.7 0.6 1.2 0.9 1.1 0.8 
DEs 1.8 1.3 1.0 0.5 2.0 1.4 1.7 1.1 
LNL 0.9 0.7 0.5 . o. Lj 0.9 1.2 0.8 0.6 
fROM RASMUSSEN, ET, AL, (121): BASED ON 1000 RESIDUES, 
* - MET AND HIS MAY REPRESENT OTHER AMINO ACIDS WHICH COCHROMATOGRAPH AS HISTIDINE AND 
METtiiONINE, 
........ 
(X) 
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possibly an a-helical structure 85 . Thus it appears that the elastin has 
a dual nature: one of an extensible portion which contains the hydropho-
bic amino acids; and another compact region, rich in alanine, which con-
tains the lysine residues responsible for the formation of the cross-
links in the mature elastin molecule 1. 
Cross-Linking Amino Acids in Elastin: 
All the known cross-links found in elastin are derived from peptidyl 
lysine 3. These cross-links account for elastin's low modulus of elasti-
city and its inherent rapid and reversible extensibility. These cross-
links maintain the gross structure of the protein as well as limit the 
amount of extensibility under stress. 
LaBella and co-workers found initial evidence for a cross-linking 
substance in 1963 when they reported finding a fluorescent component with 
a yellowish pigment in a partial hydrolysate of thoracic aorta elastin 86 . 
These investigators found that a single substance was responsible for the 
fluorescence at 405, 440, and 460 nm and that the fluorescence increased 
with age. 
Partridge and his group were studying elastin by degradation with 
proteolytic enzymes 86 , 87 . In partial hydrolysates they found amino 
acids, small peptides, and an additional fraction. This fraction con-
tained a component which had a molecular weight higher than ordinary 
amino acids, yet was not a polypeptide 86 ,87 . When this fraction was 
collected it was bright yellow in color and gave the characteristic blue-
white fluorescence of elastic tissue. The fraction was then subjected 
to further hydrolysis and two peaks were resolved by ion-exchange chroma-
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tography 86 , 87 . These two peaks were found to be very hygroscopic and 
upon titration each peak displayed 4 pK•s 12 . When the absorbance spec-
of the two compounds was determined, compound 11 A11 displayed two absor-
bance maxima, 235 and 268 nm, while compound 11 811 displayed only one maxi-
mum at 278 nm. The spectra of compounds A and B were compared to spectra 
of model compounds. It was determined that the structures resembled the 
trimethylpyridines 11 . The structures of these compounds were elucida-
ted through these studies, as well as infrared and nuclear magnetic re-
sonance spectroscopy (Fig. 1). Compound A was termed desmosine while 
compound B was termed isodesmosine. Both compounds had a MW of 543. 
Biosynthesis of Desmosine and Isodesmosine: 
Partridge and co-workers were among the first to determine that the 
cross-links in elastin were derived from peptidyl lysine 11 ,12, 35-37,83. 
They observed that when the desmosines were oxidized with alkaline ferri-
cyanide, the pyridinium ring was destroyed and lysine was liberated. 
Using pulse-chase techniques, other workers found that when 14c-lysine 
was incubated with aorta from chick embryos for 24 hours, the label ap-
peared in elastin, while the desmosines remained unlabelled 89 ,90 . Fol-
lowing a 7 day chase period of cold lysine, they observed that the des-
mosines became heavily labelled 89 . 
Partridge then injected rats with 14c-lysine daily for a period of 
10 days and isolated the desmosines and lysine from hydrolyzed aortic 
elastin 9° From these studies they determined that the ratio of radio-
activity of desmosine and isodesmosine to lysine was 4 and that it re-
quired approximately 17 days for this ratio to occur. Ultimately Part-
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ridge suggested a biosynthetic pathway whereby 4 neighboring lysine mole-
cules have 3 of their E-amino groups deaminated oxidatively, and then 
cyclize to form a pyridinium ring 58 , 90 . 
Diets deficient in copper and/or containing lathyrogenic agents, 
such as s-aminopropionitrile (BAPN) or semicarbazide, inhibit the synthe-
sis of elastin. These same agents were found to inhibit the biosynthe-
sis of the desmosines. The inhibition displayed in by a copper deficient 
diet is based on the fact that lysyl oxidase requires copper for acti-
vity. The inhibition by BAPN or semicarbazide is due to their binding 
of the aldehyde functions after the catalytic action of lysyl oxidase. 
Using two techniques for inhibiting desmosine and isodesmosine synthe-
sis, O'Dell and others found other minor cross-links were possible in 
elastin biosynthesis 91 . They utilized aorta organ culture techniques 
in the presence of lathyrogenic agents with a copper-deficient medium. 
They observed that the rate of 14c-lysine incorporation into elastin was 
not affected, but the rate of labeled lysine incorporation into desmo-
sine and isodesmosine was greatly reduced. From these results they de-
termined that other cross-links in elastin were possible 91 ,92 . 
Miller and co-workers found the condensation product of two lysine 
molecules in which one of theE-amino groups is deaminated 93 . This con-
densation results in the formation of lysinonorleucine (Fig. 2). 
Partridge found that elastin which had been reduced with -sodium 
borohydride and hydrolyzed by acid gave a peak which overlapped with ly-
sinonorleucine on amino acid analysis 88 . This compound was found to 
have an 18 carbon backbone with a molecular weight of 436 and was termed 
merodesmosine. It could be derived from the condensation product of 3 
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~H2 ~ ~H2 
CH-(CH2}4-N-(CH2)4-CH 
I I 
C02H C02H 
LYSINONORLEUCINE 
MERODESMOSINE 
Fig. 2. Structure of lysinonorleucine and merodesmosine. 
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lysine residues (Fig. 2). With further studies, it was determined that 
merodesmosine could result from two reactions: 1) the condensation of the 
Schiff base of lysinonorleucine (dehydrolysinonorleucine) with a lysine 
residue; or 2) the condensation of 2 aldehydic functions from lysine re-
sidues with another lysine residue. Both pathways resulted in the forma-
tion of dehydromerodesmosine which can then be reduced to merodesmosine. 
In summary, the biosynthetic pathway suggested by Partridge seems 
the most plausible 94- 97 . The key step in the pathway seems to be the 
oxidative deamination of the s-amino groups of selected lysine residues, 
yielding a-aminoadipic acid-o-semialdehyde. This reaction is accomplish-
ed by the action of lysyl oxidase. The aldehyde can then react in one of 
two ways: 1) formation of a Schiff base with a lysine residue yielding 
dehydrolysinonorleucine; or 2) condensation with another aldehyde via an 
aldol condensation. Dehydrolysinonorleucine can be further reduced to 
form lysinonorleucine or can form 4-hydroxy-2,3-dehyroisodesmopipyridine 
via combination with an aldol condensation product. This compound can 
then be dehydrated to form 2,3,4,5-dehydroisodesmopipyridine, which can 
spontaneously undergo oxidation to form isodesmosine (Fig. 3). If the 
aldol condensation product unites with a lysine residue to form dehydro-
merodesmosine, merodesmosine can be synthesized by a simple reduction. 
However, if the dehydromerodesmosine reacts with a-aminoadipic acid-a-
semialdehyde, 2-hydroxy-5,6-dehydrodesmopipyridine is formed, which can 
spontaneously dehydrate to form 2,3,5,6-dehydrodesmopipyridine. Desmo-
sine can then be synthesized by an oxidative reaction (Fig. 3). 
Studies with model aldehydes and amines suggest that after the 
initial enzymatic oxidation of the s-amino groups to lysyl residues, the 
Fig. 3. 
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above reactions occur spontaneously 98 , 99 . 
The amino acid sequences around the cross-linking regions have been 
elucidated 11 ,100. These areas are rich in alanine and also contain a 
high percentage of serine, glutamic acid, phenylalanine, and tyrosine. 
It was proposed by Foster and co-workers that lysines, which are preced-
ed and followed by alanine or glycine, are oxidized, but those lysine 
residues followed by large hydrophobic amino acids (particularly tyrosyl 
residues) do n~t undergo oxidation 100• Thus, the placement of the ty-
rosyl residues may determine the positions where cross-links are not 
formed 69,100 
CHAPTER 2 
PROPOSAL 
The aim of this research project is to devise a more rapid and accu-
rate method for the quantitation of the desmosines and there ~re the es-
timation of the elastin. One possible method of quantitation, proven to 
be both rapid and accurate for minute amounts af analytes, is the immuno-
assay. In all immunoassays, there is one basic reaction: 
Ab + Ag--+ Ab Ag 
where Ab is the antibody produced against a specific antigen Ag. This 
reaction depends on the specificity of the Ab for the Ag in forming the 
Ab•Ag complex. In this simple reaction, either the depletion of the Ab 
or Ag or the appearance of the Ab•Ag complex may be quantitated. How-
ever, this quantitation is usually difficult due to the amounts of Ab or 
Ag present in the reaction, and the minute amount of Ab·Ag complex formed. 
To aid in the quantitation, a label is introduced into the assay system. 
The classical label for such immunoassays is a radioisotope which 
can be attached to the Ag. In this case the reaction for a radioimmuno-
assay (RIA) is as follows: 
Ab + Ag + Ag*~Ab·Ag* + Ab·Ag + Ag + Ag* 
where Ag* is the labeled antigen. Due to the effect of mass action, the 
amount of Ag* bound to the Ab is proportional to the concentration of the 
unlabeled Ag. Thus, by varying the amount of Ag, and maintaining the Ab 
and Ag* at constant concentrations, a standard curve for the Ag may be 
constructed. The remaining necessity in RIA involves the separation of 
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the Ab•Ag* complex from the Ag*. Because this step involves a physical 
separation (double antibody; activated charcoal; solid phase separation), 
RIA is considered a heterogenous immunoassay technique. 
While RIA is a sensitive and accurate assay it has its drawbacks. 
One, for example, is the fact that the assay employs a radioisotope which 
must be handled and disposed of properly. Secondly, RIA's tend to have 
a short storage life and are expensive. 
Due to these drawbacks, a different type of immunoassay has been 
developed. This assay relies on the basic immunoassay reaction, but the 
label is an enzyme rather than a radioisotope. Instead of determining 
the activity of the isotope, enzyme activity is a measure of the Ag in 
the assay. This technique, developed by Syva, Palo Alto, Ca., is called 
an enzyme multiplied immunoassay technique (EMIT~, and relies on an 
artificially produced phenonmenon by which the enzyme activity can be 
controlled by any desired substance 103 . 
In this system, the enzyme is activated by minute quantities of Aq, 
and this activity is proportional to the concentration of the Aq present. 
This type of assay is developed by first conjugating the Aq or hapten 
(compound of less than 1000 daltons, which by itself does not elicit an 
antigenic response from the host) to an enzyme 103 . The conjugation is 
regulated such that the conjugation site is in the proximity of the re-
active site of the enzyme 103 . Finally, specific Abare produced 
against the Ag or hapten (Hp). 
With the addition of the enzyme substrate to the reaction mixture 
which contains the Ab and the enzyme-Ag (Hp) conjugate, no activity is 
detected. This inhibition is thought to be due to the inability of the 
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substrate to reach the active site of the enzyme due to physical blocking 
of the site by the Ab 103 . If, however, free Ag (Hp) is added to there-
action mixture, there will be competitive binding between the Ab and the 
enzyme-Ag (Hp) conjugate or the free Ag (Hp), allowing the enzyme tore-
act with it~ substrate, thereby displaying activity proportional to the 
amount of free Ag (Hp) present. As the concentration of the free Ag 
(Hp) increases, the Ab binds more of the free Ag (Hp) allowing more of 
the enzyme to react with its substrate, further increasing its activity. 
By varying the concentration of the free Ag (Hp), a standard curve may 
be constructed of the concentration of the free Ag (Hp} vs. enzyme acti-
vity. This type of assay is termed a homogenous immunoassay because no 
physical separation step is required. 
Several enzymes are employed with this type of assay, including egg 
white lysozyme (EC 3.2.1.17), and glucose-6-phosphate dehydrogenase (G-
6-PDase EC 1.1.1.49). 
Thus, the first part of this research project is to apply this type 
of assay to quantitating desmosine, and isodesmosine. First, they are 
conjugated to a carrier protein such as bovine serum albumin (BSA). 
Once conjugated, antibodies to both desmosine and isodesmosine can be 
produced using rabbits. Concomitant with the conjugation of the desmo-
sines to BSA, desmosine and isodesmosine are conjugated to several en-
zymes, including lysozyme and glucose-6-phosphate dehydrogenase. Once 
these preliminary steps are achieved, an enzyme immunoassay system is 
possible for the quantitation of the desmosines. 
Another potential method for the quantitation of the desmosines from 
elastin is amino acid analysis via high performance liquid chromatography 
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(HPLC). Several methods now exist for amino acid analysis by HPLC uti-
lizing several different separation techniques 104- 106 . These techniques 
include the derivatization of the amino acids with a fluorogenic compound 
followed by reverse phase HPLC separation 104 , separation of underivati-
zed amino acids by ion-suppression 105 , or the separation of the amino 
acids by ion-exchange HPLC 106 . Another possible means of separating the 
amino acids is by ion-paired HPLC, which in essence creates a pseudo-ion-
exchange column and also employs some of the characteristics of a reverse 
phase column. 
High performance liquid chromatography is a technique whereby a com-
plex mixture can be readily separated and each component quantitated. 
While its fundamental theories were drawn from gas liquid chromatography 
(GC), HPLC has supplanted GC in many areas of analytical work, especially 
in the analysis of non-volatile or thermally labile compounds. 
An HPLC system usually consists of a pump, a column, and a detector. 
Of these three, the column is the most important for it is the column 
which actually does the separating of the various components of the mix-
ture. It achieves this separation by the interaction of the compound 
with both the stationary phase (column packing) and the mobile phase 
(eluting solvent). This interaction varies according to the stationary 
phase and the mobile phase employed in the separation. 
The interaction of the compound with the various phases on the 
column can be quantitated by the various parameters, k', a, Rs, and N. 
The capacity factor, k', is a measure of the retention of the compound 
on the column for that particular system. It can be calculated by the 
equation: 
k' = 
v1 - vo 
vo 
where v1 is the retention volume of the compound of interest; v0 is the 
void volume of the column. 
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The separation factor, a, is a measure of the ability of the chroma-
tographic system to separate two components of a mixture, and is defined 
as the ratio of the k' of the two components: 
k' 
a= _2_ 
k' 1 
where k2 is the capacity factor for the longer retained component. 
The resolution factor, Rs, expresses the separation of the two peaks 
and includes the average peak width as well as the peak to peak separa-
tion. It is calculated as follows: 
v2 - v1 R = -____;;;~__;;;..,__ 
s 1/2(w1 + w2) 
where w1 and w2 are the width of the two peaks at the baseline. Baseline 
resolution of the two peaks would correspond to an R5 value of 1.5 
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. 
Finally, the theoretical plate number, N, which is a term used for 
comparative purposes, describes the efficiency of the column. The ef-
ficiency is calculated as follows: 
N = (t/w) 2 
where t is the retention time of the peak and w is the width (em) of 
r 
the peak at baseline. With this number the efficiency of two different 
columns can be compared for a particular compound providing all other 
operating parameters remain constant. 
As stated earlier, there are different types of HPLC. These include 
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adsorption or liquid-solid chromatography, partition or liquid-liquid 
chromatography, and ion-exchange chromatography. In adsorption chromato-
graphy, the components to be separated are bound to the surface of the 
column packing, and this bonding is dependent on the functional qroups 
on the molecule. The common adsorbants are silica gel and alumina. In 
adsorption chromatography the stationary phase is polar while the mobile 
phase is non-polar. 
In ion-exchange HPLC, retention is the result of two simultaneous 
processes: 1) the distribution of compounds between the mobile phase, 
usually polar, and the organic stationary phase; 2) reaction with the 
ionic sites within the stationary phase. These ionic sites usually con-
sist of R-so3- groups for cation exchange columns or R-N(CH 3); groups 
for anion exchange columns. Classically, ion-exchange columns have been 
utilized for amino acid analysis. 
Partition chromatography relies on the partitioning of the solute 
between two phases, mobile and stationary, and the functionality of the 
solute for separation. This type of chromatography is the most widely 
used method for HPLC analysis. Partition chromatography is divided into 
two types, normal and reverse phase. In normal phase, so named due to 
historically being the first used, the stationary support is coated 
(bonded) with a polar moiety, while the mobile phase is relatively non-
polar. Typically, normal phase supports are bonded to cyano (CN), amine 
(NH2), or hydroxyl (OH) compounds. 
In reverse phase chromatography, the stationary phase support is 
bonded, via siloxanes, to non-polar groups, usually c2 to c18 alkanes. 
Of these, the most widely utilized is the octadecylsilane (ODS). The 
32 
retention mechanism for reverse phase HPLC is more complex than classical 
forms. In reverse-phase HPLC, the mobile phase is of higher polarity 
than the stationary phase; thus polar substances tend to elute prior to 
less polar. This is just opposite to the results obtained from a normal 
phase column. 
There are 3 possibilities for the separation mechanism in reverse 
phase: 1) partitioning of the solute between the non-polar stationary 
phase and the polar mobile phase; 2) adsorption of the solute to the non-
polar functions of the stationary phase; and 3) partitioning of the so-
lute molecules between the mobile phase and a 11 new" stationary phase 
which is the organic modifier (usually methanol or acetonitrile) added to 
the mobile phase and adsorbed onto the stationary phase 107 . 
Ionized compounds, such as amino acids, elute very quickly or yield 
poorly defined peaks with severe tailing on a reverse phase column. 
There are several ways to suppress the ionization of the molecules to aid 
in their separation. One such way is to chemically modify the ionic spe-
cies by bonding another molecule of less polarity to it 104 . Usually 
this derivatization process not only decreases the ionization of the rna-
lecule (polarity), but also usually produces a chromophore which enhances 
the detection of the molecule 104 Another method for controlling the 
ionization of the molecule is by controlling the pH of the mobile phase 
in order to suppress the ionization of the molecule. This technique is 
called ion-suppression, and is useful for weak acids and bases in the pH 
range of 2 to 8. This technique cannot be used with strong acids and 
bases which remain ionized in that pH range. 
When using strong acids or bases, another technique is available for 
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their separation. With this technique the tailing and poor peak shapes 
can be circumvented by forming ion pairs with a counter ion dissolved 
in the mobile phase. This ion-pair chromatography (IPC) technique has 
several possible modes of retention.of a solute. One mode is the actual 
pairing between the sample and the counter ion, thereby decreasing the 
polarity as shown below: 
+ 
A(aq) + B(aq)---7AB(org) 
where A+ is the aqueous sample; 8- is the counter ion in the mobile 
phase; and AB is the ion paired species. Another possible mechanism is 
the conversion of the reverse phase column to a pseudo-ion-exchange co-
lumn, thereby possessing both characteristics of a reverse phase column 
and an ion-exchange column. The actual separation mechanism may be a 
combination of the two processes 107 . 
In this part of the research, the desmosines are separated and 
quantitated by several of the described HPLC techniques, including ion-
exchange HPLC, ion-suppression HPLC, derivatization with a fluorogenic 
compound, and finally by ion paired HPLC. 
CHAPTER 3 
METHODS AND MATERIALS 
PURIFICATION OF DESMOSINE AND ISODESMOSINE 
Commercially prepared desmosine and isodesmosine (Elastin Products, 
St. Louis, Mo.) were dissolved in 5.0 mL of 0.2 mol/L sodium citrate 
buffer, pH 2.20. This solution was then applied to a jacketed column, 
85 x 5 em, packed with Aminex ~1s "C" resin. The column temperature was 
maintained at 45 °C with a circulating water bath. The flow rate was 
maintained at 12.0 mL/min. The column was first eluted with approxi-
mately 100 mL of 0.2 mol/L sodium citrate buffer, pH 3.25, followed by 
1.0 L of 0.38 mol/L sodium citrate buffer, pH 4.00. The desmosine or 
isodesmosine was then eluted with 0.38 mol/L sodium citrate buffer, pH 
5.65. 
The eluted desmosine or isodesmosine was then lyophilized and re-
dissolved in a minimum of 0.1 mol/L hydrochloric acid and quantitatively 
transferred to a 45 x 2 em column packed with Dowex 50WX8 cation exchange 
resin, 50-100 mesh, in the hydrogen form. The salts were eluted with 3.0 
L of glass distilled, deionized water at a flow rate of 9.0 mL/min and 
the desmosine or isodesmosine was then eluted with 0.5 mol/L ammonium hy-
droxide. This solution was then lyophilized. 
Following the elution of the desmosine or isodesmosine, the hydrogen 
form of the cation exchange resin was regenerated. 
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AMINO ACID ANALYSIS 
The purity of the desmosines, as well as the amino acid analysis of 
the protein and tissue hydrolysates, was accomplished with a Beckman 121 
camino acid analyzer. The analyzer utilized an 11.0 x 0.9 em jacketed 
column packed with PA-35, a sperical 7.5% cross-linked sulfonic acid re-
sin, with a mean particle size of 13.0 ± 0.6 mm. The column temperature 
was maintained at 56 °C. 
The automatic program (Fig. 4) employed for the separation and quan-
titation of the amino acids was as follows. The samples were diluted 
with 0.2 mol/L sodium citrate buffer, pH 2.20. Of this dilution 0.5 ml 
was injected and the column was first eluted with 0.2 mol/L sodium ci-
trate buffer, pH 3.45 for 15 min, followed by a second elution with 0.35 
mol/L sodium citrate buffer, pH 4.25 for 60 min. The final eluting buf-
fer was 0.35 mol/L sodium citrate, pH 5.25, for a period of 60 min. All 
buffers were pumped at approximately 100 psig, at a flow of 68 ml/min. 
Following the elution of the amino acids~ the column was regenerated 
with 0.2 mol/L sodium hydroxide, followed by column equilibration with 
the initial buffer. All buffers contained 0.4 ml of 25% thiodiglycol/L 
to establish a reducing environment and 1.0 ml of toluene/L to retard 
bacterial growth. 
The eluted amino acids were detected by reaction with ninhydrin. 
The ninhydrin was prepared according to the Beckman amino acid manual. 
SPECTRA DETERMINATION OF DESMOSINE AND ISODESMOSINE 
The purified desmosine or isodesmosine (5.43 mg each) was dissolved 
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Fig. 4. Automated program employed on the Beckman 121 C amino acid analyzer. 
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in 10.0 ml of deionized, glass distilled water, hereafter referred to as 
water. Each solution was scanned against a water blank from 340 to 190 
nm with a Perkin-Elmer recording spectrophotometer. 
CONJUGATION AND ANTIBODY PRODUCTION 
Purification of the Glutaraldehyde Solution: 
To 100 ml of commercially prepared 25% glutaraldehyde (Sigma Chemi-
cal Co., St. Louis, Mo.), 15 to 25 g of activated charcoal was added and 
throughly mixed. This mixture was then filtered through a 0.45 ~m milli-
pore filter. This procedure of Anderson was performed several times un-
til the filtrate changed from a straw yellow color to a clear solution 
with a 11 fruity 11 fragrence 109 . The spectrum of the purified glutaralde-
hyde was then recorded from 340 to 200 nm with a Beckman DB-1 recording 
spectrophotometer and compared to the literature spectrum 109. 
Conjugation of the Desmosines to Bovine Serum Albumin: 
The purified desmosine or isodesmosine was conjugated to bovine 
serum albumin via a modified method of several authors 110-114. In this 
procedure, 50 mg (0.735 nmol) of bovine serum albumin (BSA) was dissolved 
in 9.78 ml of 0.1 mol/L sodium acetate buffer, pH 5.0. To this was added 
24.0 mg (44.2 nmol) of desmosine or isodesmosine. These amounts were 
added to establish a desmosine or isodesmosine to BSA ratio of 60 114 . 
While slowly stirring, a purified 2% glutaraldehyde solution was added 
dropwise in various amounts to establish a glutaraldehyde to desmosine or 
isodesmosine mol ratio of 1 to 4 114 . The mixture was allowed to react 
for 3 hours at room temperature, after which the mixture was centrifuged 
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at 1,000 x ~for 20 min to remove any protein-protein macro-conjugates. 
The remaining supernatant was either dialyzed against water at 4 °C for 
24 hours or placed on a Sephadex G-50 column (45 x 1 em) and eluted with 
0.1 mol/L sodium acetate buffer, pH 5.0. The eluant was monitored at 280 
nm. The protein conjugate eluted from the column was then dialyzed 
against water for 24 hours at 4 °C to remove the buffer. The dialysate 
was then lyophilized and stored dessicated at 0 °C until needed. 
All other conjugation procedures were modifications of this method. 
Conjugation of the Desmosines to Lysozyme: 
Purified desmosine or isodesmosine was conjugated to lysozyme (EC 
3.2.1.17, Sigma Chemical Co., St. Louis, Mo.), by the method previously 
described for BSA with the following modifications. Fifty mg of lysozyme 
(3.47 x 10-6 mol) was dissolved in 9.78 mL of 0.066 mol/L potassium phos-
phate (monobasic) buffer, pH 6.24. To this solution was added 113 mg of 
desmosine or isodesmosine (2.083 x 10-4 mol), followed by the addition 
of 1.05 mL of a 2% glutaraldehyde solution (2.083 x 10-4 mol), dropwise. 
Following the conjugation reaction and centrifugation, the superna-
tant was dialyzed against water for 24 hours at 4 °C, lyophilized and 
stored desiccated at 0 °c. 
Conjugation of the Desmosines to Glucose-6-Phosphate Dehydrogenase: 
Purified desmosine or isodesmosine was conjugated to glucose-6-phos-
phate dehydrogenase (EC 1.1.1.49, Sigma Chemical Co., St. Louis, Mo.), 
grade IV, by the method previously described for BSA with the following 
modifications. One ml of a glucose-6-phosphate dehydrogenase solution, 
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containing 2.05 mg (2.05 x 10-5 mol) protein, was added to 3.97 mL of a 
0.1 mol/L Tris buffer, pH 7.6. To this was added 0.67 mL of a desmosine 
or isodesmosine solution (1 mg/mL; 1.23 x 10-4 mol). While slowly stir-
ring, 0.013 mL of a 2% glutaraldehyde solution was added dropwise. 
Following the conjugation reaction and centrifugation, the superna-
tant was dialyzed against water for 24 hours at 4 °C, lyophilized, and 
stored desiccated at 0 °C. 
Determination of Lysozyme Activity: 
Lysozyme, grade I, from egg whites, was assayed by a modified pro-
cedure of Shugar 115 . The substrate, Micrococcus lysodeikticus (Sigma 
Chemical Co., St. Louis, Mo.) was prepared by adding approximately 1.5 mg 
~- lysodeikticus to 10.0 mL of 0.066 mol/L potassium phosphate buffer, pH 
6.24. The absorbance of this solution was adjusted to between 0.6 and 
0.7 at 450 nm with buffer. Of this adjusted substrate suspension, 0.625 
mL was added to a micro silica cuvette. To this was added 0.1-0.2 mL of 
either buffer or prepared antisera and mixed. Finally, 0.1 mL of a ly-
sozyme solution or lysozyme-desmosine or isodesmosine conjugate solution 
(1.0 mg lysozyme or lysozyme conjugate dissolved in 10.0 mL of 0.066 
mol/L potassium phosphate buffer, pH 6.24) was added and quickly mixed 
by inversion. Following an initial equilibration period of between 15 
and 120 seconds, the absorbance at 450 nm (A450 ) was recorded every 30 
seconds. The A450 was recorded for a period of 2 to 4 min following the 
initial equilibration, and the relative rate, A450 change/min (6A450 ) was 
determined. 
This assay was utilized to determine the rate of the reaction for 
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unconjugated and the conjugated enzyme, as well as for titering the anti-
sera for the quantitation of the desmosines. 
Determination of Glucose-6-Phosphate Dehydrogenase Activity: 
Glucose-6-phosphate dehydrogenase activity was assayed by a modified 
procedure of Bergmeyer et al 116 . The activity was determined by the 
change in absorbance at 340 nm. The assay was as follows: 2.95 ml of a 
0.1 mol/L Tris buffer, pH 7.6, containing 6.9 mmol/L magnesium chloride, 
1.0 mmol/L glucose-6-phosphate, and 0.39 mmol/L nicotine adenine dinu-
cleotide phosphate (NADP) was added to a 3.0 ml cuvette. At time zero, 
0.02 ml of a glucose-6-phosphate dehydrogenase (G-6-PDase) solution (2.05 
mg protein/ml buffer) was added to the sample cuvette and mixed. The re-
ference cuvette contained 2.92 ml of 0.1 mol/L Tris buffer, pH 7.6, con-
taining the various cofactors. The absorbance at 340 nm was recorded for 
a period of 5 min and the relative rate, A340 change/min was determined. 
This assay was utilized to determine the rate of the reaction for 
the unconjugated and the conjugated enzyme for the quantitation of the 
desmosines. 
Production of Antibodies to Desmosine and Isodesmosine: 
Various amounts of lyophilized BSA-desmosine or BSA-isodesmosine 
conjugates (2.5 to 5.0 mg) were dissolved in a minimal amount of sterile 
normal saline. An equal volume of Freund•s complete adjuvant was added 
and the mixture was emulsified by repeatedly aspirating and expelling the 
mixture from a sterile glass syringe fitted with a 21 gauge needle 117 
A frothy white appearence indicated complete emulsification. 
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The emulsified mixture was administered by a modified method of Vai-
tukaitis et al 117 . The fur was shaved from the back and proximal limbs 
of New Zealand white rabbits, and the emulsion was injected intradermally 
at 15 to 20 sites, such that each rabbit received a total of 2.0 mL. 
Following the initial inoculation, booster injections of from 2.5 
to 5.0 mg of emulsified conjugates (Freund•s incomplete adjuvant) were 
administered intramuscularly bi-weekly. After 8 weeks the rabbits were 
bled 117. Bleeding was accomplished via the central ear artery, follow-
ing the shaving of the ear and application of xylene for vasodilitation. 
The blood was collected into sterile 10 ml glass syringes, and transfer-
red to silicone coated vacutainers. Two to 4 ml of blood was collected 
from each rabbit per bleeding. After clotting and centrifuging, the 
sera were frozen in 1.0 ml aliquots. Booster injections were continued 
throughout the course of bleeding the rabbits. 
During the course of these procedures, the rabbits were housed at 
the animal research facility, Loyola University Medical Center, and fed 
standard lab chow and allowed water ad lib. 
Titering of the Antisera: 
The antisera collected from the rabbits were diluted 1:1, 1:10, 
1:100, and 1:1000 with either 0.066 mol/L potassium phosphate buffer, 
pH 6.24, or 0.1 mol/L Tris buffer, pH 7.6 to be used in the lysozyme or 
G-6-PDase assays, respectively. The various dilutions were then added to 
their respective assays, as previously described, and the relative rate 
of the reaction calculated for each. 
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3H-Isodesmosine Conjugation to BSA: 
To 24.0 mg of unlabeled isodesmosine, approximately 0.5 ml of 3H-
isodesmosine (0.02 mg; ~100 ~Ci), prepared by Amersham (Arlington Heights, 
IL.) was added. This mixture was then conjugated to BSA as previously 
described with an isodesmosine to BSA ratio of 60 and a glutaraldehyde to 
isodesmosine ratio of 1. Following its lyophilization, the conjugate was 
dissolved in a minimum amount of glass distilled, deionized water. To 
this was added 8.0 mL of scintillation fluor (4% PPO, 10% BSS, toluene, 
w/v) and the conjugate was counted to a 0.2% error in a Beckman scintil-
lation counter. 
HPLC DETERMINATIONS 
All HPLC determinations for desmosine or isodesmosine utilized a 
Water•s M-6000 pump system connected to a Water•s U6K injector fitted 
with a 2.0 ml injection loop. The amino acids were detected with either 
a Water•s M-440 dual wavelength detector (254 and 280 nm) or a Water•s 
M-450 variable wavelength detector at 205 nm, or a Water•s M-420 fluor-
escence detector (334 nm excitation, 450 nm emission). An Omniscribe 
dual pen recorder was utilized to quantitate the various amino acids as 
they eluted via the peak height method. All injection were made with a 
Hamilton 50 ~L syringe, designed for the Water•s injector. 
Ion-Exchange HPLC: 
For all ion-exchange determinations, a Whatman SCX/Partisil 10, 25 x 
0.4 em column was utilized. The column consisted of sulfonic acid func-
tional groups bound to inert particles 10 ~m in size. For determina-
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tions the amino acids were first dissolved in 0.1 mol/L potassium hydro-
xide (10 mg amino acid/50 ml). Five ~L of each were injected onto the 
column and eluted with 0.2 mol/L ammonium phosphate (dibasic) buffer, 
with the pH varied from 2.5 to 3.5. The mobile phase was maintained at 
a constant flow of 0.7 ml/min (300 psig). The amino acids were detected 
at either 280, 245, or 205 nm as they eluted from the column. 
Reverse Phase and Ion-Suppression HPLC: 
For all reverse phase and reverse phase-ion suppression HPLC deter-
minations a Water's C-18 ~-Bondapak 30.0 x 4.0 mm, 10 ~m particle size, 
column was utilized. This column consists of octadecyl alkane moieties 
chemically bonded to silica particles. The amino acids were separated 
and quantitated by a modified method of Hancock 104 . In this procedure, 
5 to 10 ~L of the amino acid solutions (10 mg amino acid/50 ml water) 
were injected onto the column and eluted with a mobile phase, which con-
sisted of a methanol/water/phosphoric acid solution, which varied from 
0/99/1 to 40/59/1 (v/v). The pH varied from 2.5 to 6.0. The flow rate 
was maintained at 1.0 mL/min (1800 to 2500 psig, depending on the methan-
ol percentage of the mobile phase). The amino acids were detected at 205 
nm as they eluted from the column. 
Derivatization with ortho-Phthaldialdehyde: 
The methods of Lindroth and Mop per 105 , and Gardner and ~·1i 11 er 106 , 
were employed for the derivatization and detection of the amino acids. 
The method utilized a pre-column derivatization procedure prior to the 
injection of the amino acids onto the C-18 column. Again a Water's C-18 
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column was utilized. The amino acids were derivatized with o-phthaldal-
dehyde (OPA) reagent, which consisted of 270 mg OPA (Sigma Chemical Co., 
St. Louis, Mo.) dissolved in 5.0 mL of absolute ethanol. To this was 
added 200 ~L of 2-mercaptoethanol. The OPA reagent was then made to 500 
mL with 0.4 mol/L boric acid, pH 9.5. 
To derivatize the amino acids, 100 ~L of OPA reagent was added to 20 
~L of the sample, and allowed to react at room temperature for 2.0 min. 
Ten ~L of the derivatized sample was then injected onto the column and 
eluted with 0.05 mol/L sodium phosphate (monobasic) buffer, pH 7.3, with 
the methanol percentage varied between 50 ~nd 95%. The mobile phase was 
maintained at a constant flow of 1.0 mL/min, and the amino acids were 
detected as they eluted from the column by fluorescence, at an excitation 
wavelenth of 340 nm and an emission wavelength of 450 nm. 
Ion-Paired HPLC: 
This method of separation (PIC R Supplement, Water•s Inc.) utilized 
the sodium salt of heptane sulfonic acid (Eastman Kodak Co., Rochester, 
N.Y.) as the counter ion. For separation of the desmosines, this system 
employed either a Water•s C-18 column as previously described or a Bio-
Rad ODS-5, 15 em x 4 mm i.d., C-18 column (5 ~m particle size). The 
amino acids either from standards or from hydrolysates were eluted with 
a methanol/water solvent, with the methanol percentage varied between 19 
' 
and 30%. The solvent contained 0.01 mol/L heptane sulfonic acid, sodium 
salt, and was adjusted to pH 3.0 with phosphoric acid. The mobile phase 
was maintained at a constant flow of 1.0 mL/min (1000 to 2500 psig, de-
pending on the methanol percentage in the mobile phase). The eluted 
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amino acids were detected at either 205, 254, or 280 nm and were quanti-
tated by peak height, as compared to a standard curve. 
Tissue Preparation: 
Tissue samples from both canine and human aortas were first cleaned 
by removing any plaque and fat deposits which were visibly present. The 
tissue was minced and weighed to yield a wet weight of from 2 to 4 g. 
The minced tissue was then dried at 60 °C at 0.05 mm Hg pressure over-
night to a constant weight. The dried tissue was then defatted by a 
series of ethanol, ethanol-ether (1:1), and finally ether extractions. 
The tissue was again dried and weighed to yield a fat free dry weight 
(FFDW). 
The FFDW tissue was then hydrolyzed at 110 °C for 48 hours with 6 
mol/L hydrochloric acid. Following hydrolysis, 20 to 30 mg of activated 
charcoal was added to the hydrolysate and the mixture was again heated to 
60 °C with agitation for 10 min, followed by filtering through a 3 ~m 
Millipore filter to remove the charcoal. 
For amino acid analysis by the Beckman 121 C, the hydrolysate was 
diluted with 0.2 mol/L sodium citrate buffer, pH 2.2, and analyzed as 
previously described. For analysis by HPLC, the hydrochloric acid had 
first to be removed. This was accomplished by a series of washings with 
water, each followed by evaporation under vacuum. Once the hydrochloric 
acid was removed, the hydrolysate was diluted to final volume with glass 
distilled, deionized water. 
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RECOVERY STUDIES OF THE DESMOSINES USING HPLC 
Recovery from Hydrolyzed BSA: 
To determine the analytical recovery and to check the linearity of 
the ion-paired HPLC method, desmosine and isodesmosine were added to BSA, 
prehydrolysis. In this method, 50 mg of BSA was added to consecutively 
numbered hydrolysis tubes. To the first tube, no desmosine or isodesmo-
sine was added. To the remaining tubes, desmosine and isodesmosine were 
added in various amounts to achieve the following concentrations: Tube 2, 
0.0224 and 0.0130 mmol/L; tube 3, 0.0448 and 0.0180 mmol/L; tube 4, 
0.0597 and 0.0265 mmol/L; and to tube 5, 0.0784 and 0.0397 mmol/L, desmo-
sine and isodesmosine, respectively. The BSA was then hydrolyzed as pre-
viously described, followed by the determination of the desmosines. 
Recovery from Hydrolyzed Canine Aorta: 
The above recovery studies were then repeated substituting prepared 
canine aorta for the BSA. Once the initial desmosine and isodesmosine 
concentration of the aorta sample was determined, the remaining tissue 
was spiked {prehydrolysis) with desmosine and isodesmosine to achieve the 
following concentrations of desmosine and isodesmosine, respectively: 
0.056 and 0.049 mmol/L; 0.060 and 0.056 mmol/L; 0.070 and 0.061 mmol/L; 
0.072 and 0.066 mmol/L; and finally 0.080 and 0.078 mmol/L. The spiked 
aorta samples were then hydrolyzed and the desmosine and isodesmosine 
concentrations determined, as previously described. 
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COLLAGEN DETERMINATIONS 
Hydroxyproline Determinations: 
The collagen content of all the tissue hydrolysates was determined 
by the method of Blumenkrantz and Asboe-Hanson 40 In this method, the 
hydroxyproline content is correlated to the amount of collagen present in 
the tissue. For this method, 1.0 mL of hydrolysate was mixed with 1.5 mL 
of a borate-alanine buffer, pH 8.7 and 600 uL of a 0.2 mol/L chloramine T 
solution. Following a 20 min reaction time, 2.0 mL of a 3.6 mol/L thio-
sulfate solution was added and throughly mixed. Sodium chloride was then 
added to the mixture to saturation levels. After a 20-30 minutes, 3.0 
mL of toluene was added to the.tube , followed by heating at 100 °C in a 
water bath. The tubes were then cooled and allowed to set for 15 min 
followed by a slow speed centrifugation for 10 min. 
One mL of the organic layer was then removed and mixed with 0.4 ml 
of Ehrlich's reagent (Appendix A). After a 30 min reaction time in the 
dark, at room temperature, the solution was read in a spectrophotometer 
at 565 nm against a reagent blank. The A565 was compared to a standard 
curve for hydroxyproline. 
CHAPTER 4 
RESULTS 
PURIFICATION OF THE DESMOSINES 
From the amino acid analysis of the commercially prepared desmosine 
and isodesmosine, it was observed that mutiple unknown peaks appeared on 
the aminograms. Since the desmosines would be used in the conjugation 
reactions, it was decided that they should be further purified. The des-
mosines were then purified as described in Chapter 3. 
Two criteria were used to judge the purity of the desalted, purified 
desmosines, the first being a single eluting peak on amino acid analysis, 
and secondly a comparison of their respective ultra-violet (UV) spectra 
to those published. Following their purification, desmosine and isodes-
mosine were both found to elute as single peaks on amino acid analysis, 
at 70 and 78 min, respectively, devoid of any extraneous peaks first ob-
served on amino acid analysis of the unpurified desmosines (Figs. 5,6). 
These purified fractions were then subjected to UV analysis, as previous-
ly described. Both desmosine and isodesmosine were found to display UV 
absorption in the 200 to 280 nm range, desmosine displaying its charac-
teristic bi-modal absorption spectrum, having absorbance maxima at 238 
and 268 nm, with a slight inflection at 273 nm (Fig. 7), while isodesmo-
sine displaying its characteristic single absorption maximum at 278 nm, 
with an inflection at 217 nm (Fig. 8). Both these obtained spectra cor-
related well with those previously published 8,9 
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Fig. 7. Ultraviolet spectrum of purified desmosine. 
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52 
53 
Therefore, from the results obtained from amino acid analysis and UV ana-
lysis, it was determined that the desmosine and isodesmosine preparations 
were pure. The purified desmosine and isodesmosine, hereinafter referred 
to as desmosine and isodesmosine, were used in the conjugation and anti-
body production phase of the research, as \'le 11 as for the standards in 
all automated amino acid analysis and HPLC method development. 
CONJUGATION AND ANTIBODY PRODUCTION 
Purification of Glutaraldehyde: 
In order to elicit an antigenic response from the inoculated rab-
bits, desmosine or isodesmosine first had to be conjugated to a carrier 
molecule, BSA fraction V. It was decided that this conjugation of either 
Des or Ide to BSA should be attempted via a reaction with glutaraldehyde. 
However, before attempting this conjugation, the commercially prepared 
25% glutaraldehyde was purified. This purification involved the stirring 
of the glutaraldehyde solution with activated charcoal, as described in 
Chapter 3. According to the literature, an absence of an absorbance 
peak at 235 nm, as well as the solution being clear and colorless with a 
distinct "fruity" fragrance, are all indicative of a pure solution 109 . 
In the commercially prepared solution of glutaraldehyde, a strong ab-
sorption peak was noted at 235 nm and the solution had a yellowish tinge. 
However, on treatment with activated charcoal, the filtrate was observed 
to be clear and colorless, with a "fruity" fragrance. The purified so-
lution also did not display any absorption peak at 235 nm. Using the 
before mentioned criteria, it was determined that the glutaraldehyde 
solution was pure and suitable to be utilized in the conjugation reac-
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tion. 
Conjugation of the Desmosines to BSA: 
Following the purification of the desmosines, and the glutaraldehyde 
solution, conjugation of either Des or Ide to BSA was attempted, as pre-
viously described in the methods. In all conjugation studies the mol 
ratio of Des or Ide to BSA was maintained at 60:1, with the mol ratio of 
glutaraldehyde to Des or Ide varied from 1:1 to 10:1. 
During the course of the conjugation reaction, it was noted that the 
mixture changed from a clear, colorless solution to a straw yellow color, 
and that a white flocculant precipitate formed. Upon completion of the 
reaction, the solution was placed on a Sephadex G-50 column, and eluted 
with the appropriate buffer. The eluant was monitored at 280 nm and 2 
peaks were observed (Fig. 9). The first peak eluted with the void vo-
lume, while the second eluted at approximately 60 ml. The first peak was 
found to contain the protein portion of the reaction, while the second 
peak contained the unconjugated Des or Ide. No attempt was made to quan-
titate the unconjugated Des or Ide. The white flocculant precipitate 
which formed was thought to be protein-protein macroconjugates, which 
form as a side reaction to the conjugation process 114 . 
Following the initial conjugation, the glutaraldehyde (Glu) to Des 
ratio was varied from 1-10. In these conjugation reactions, the appear-
ence, color and the amount of precipitation was qualitatively noted. 
Finally, the amount of protein remaining in the supernatant, following 
the 1,000 x ~centrifugation, was quantitated by the Lowry method. 
Table 5 shows the results of the various conjugation conditions uti-
2.0 
1.5 
0 ~ 1.0 
< 
0.5 
0 20 40 60 80 
mL eluant 
Fig. 9. Elution profile of conjugation reaction mixture applied 
to a Sephadex G-50 column, and eluted with 0.1 mol/L 
sodium acetate buffer, pH 5.0. BSA-Desmosine conjugate 
and unreacted desmosine detected at 280 nm. 
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TABLE 5 
DETER,"1INATION OF GLUTARALDEHYDE TO DES~10SINE RATIO 
IN BSA-DESMOSINE CONJUGATION 
AMOUNT 
GLU/DES APPEARANCE* PRECIPITATION** PROTEIN*** 
0 CLEAR NONE 48 MG 
1 liGHT YELLOW SLIGHT 46 MG 
2 STRAW YELLOW ~10DERATE 40 MG 
3 YELLOW MODERATE-HEAVY 20 MG 
4 YELLOW HEAVY 0 MG 
DETERMINATION OF GLUTARALDEHYDE TO DESMOSINE RATIO FOR CONJUGATION OF 
DESMOSINE TO BSA, RATIOS ARE MOLAR AND BASED ON A DESMOSINE TO BSA 
RATIO OF 60 USING 50 MG OF BSA IN THE REACTION, 
• 
•• 
*** 
APPEARANCE OF REACTION MIXTURE FOLLOWING 3 HR, AT ROOM TEMPERATURE, 
RELATIVE AMOUNT OF PRECIPITATE FOLLOWING CENTRIFUGATION, 
PROTEIN REMAINING IN SUPERNATANT FOLLOWING CENTRIFUGATION, 
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ized to determine the optimum glutaraldehyde to Des or Ide ratio. It was 
noted that as the glutaraldehyde to Des ratio was increased from 1 to 4, 
the amount of protein precipitation increased, with a concomitant de-
crease in the amount of protein remaining in the supernatant. It was also 
observed that during the course of the reaction, the appearance of the 
mixture changed from a colorless solution to a dark yellow, the color de-
pendent on the glutaraldehyde to Des ratio. 
From these findings, it was determined that all conjugation reac-
tions would utilize a glutaraldehyde to Des or Ide ratio of 1 in order 
to assure a maximum yield of conjugate (protein remaining in the super-
natant) with a minimum of precipitation. 
Conjugation of the Desmosines to Lysozyme or G-6-PDase: 
Des or Ide was conjugated to lysozyme and G-6-PDase as previously 
described in the methods. The glutaraldehyde to Des or Ide ratio was 
maintained at 1 (as determined in their conjugation to BSA) in order to 
minimize any protein-protein macrocomplexes, which would decrease the 
amount of available enzyme. No visible precipitation was noted upon the 
completion of the conjugation reaction; however, following the centrifu-
gation, a minute amount of a white precipitate was noted. 
In order to determine the loss of lysozyme activity due to the con-
jugation procedure, unconjugated lysozyme activity was compared to that 
of the lysozyme-Des or -Ide conjugate. When the two were normalized to 
mg protein, a substantial decrease was noted in the conjugated enzyme 
(9.05 ± 0.16 ~A/min/mg vs. 1.37 ± 0.07 ~A/min/mg, respectively). This 
decrease amounts to a loss of approximately 85% of the unconjugated lyso-
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zyme activity. This loss, however, was not unexpected, as loss of enzyme 
activity upon conjugation has been reported 110 , 111 , 113 Even with the 
85% loss of activity, it was decided that the remaining activity should 
be sufficient for the quantitation of the desmosines utilizing lysozyme. 
Glucose-6-phosphate dehydrogenase activity was also compared between 
the unconjugated and conjugated enzyme. In these assays the rates were 
normalized to units of activity. Upon normalization, it was found that 
51% of the unconjugated enzyme activity was lost due to the conjugation 
process (2.05 ± 0.04 6A/min/unit vs. 1.23 ± 0.06 6A/min/unit). 
Of the two enzyme assays, there was a greater sensitivity, as well 
as a greater yield of active enzyme, with G-6-PDase. However, both en-
zymes were utilized to titer the antisera, in order to determine which 
enzyme was better suited for the quantitation of the desmosines. 
Antibody Production: 
Bovine serum albumin-desmosine or isodesmosine conjugates were in-
jected into New Zealand white rabbits as previously described. A total 
of 8 rabbits (4 groups) were inoculated with either 2.5 or 5.0 mg conju-
gate/injection. Rabbits 1 and 2 recieved 2.5 mg BSA-Des conjugate/injec-
tion, while rabbits 3 and 4 received 5.0 mg BSA-Des conjugate/injection. 
Rabbits 5 and 6, and 7 and 8, were injected with 2.5 and 5.0 mg BSA-Ide 
conjugate/injection, respectively. 
Following the initial inoculations, lesions developed at the sites 
of the injections. These lesion eventually cleared, and no other gross 
problems were encountered during the course of the antibody production. 
The initial bleeding of the rabbits occurred after 8 weeks, and was 
continued every 2 weeks thereafter, up to 16 weeks. Booster injections 
were administered every 2 weeks, with Freund•s incomplete adjuvant, and 
continued throughout the 16 weeks. 
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The antisera collected from each bleeding were diluted to various 
titers {1, 1:1, 1:10, 1:100, 1:1000) with buffer used for each enzyme. 
These various titers were then assayed for antibody activity utilizing 
both the Des or Ide conjugated lysozyme or G-6-PDase preparations. If 
antibody activity was present, then a decrease in enzyme activity {rate) 
from the control activity {sera from untreated rabbits) should be obser-
ved. When the various antisera obtained from the rabbits over several 
bleedings were assayed, no decrease in either enzyme activity from con-
trol values were noted (Tables 6-9). The specific data shown is for the 
final bleeding at 16 weeks. No differences were noted between the rab-
bits in each group, or the time interval from the initial inoculations. 
It was noted that the enzyme activity substantially increased when any 
serum (both control and antiserum) was added to the assay mixture. This 
increase is thought to be due, in part, to non-specific activation of 
the enzymes by the proteins or the co-factors present in the serum of 
the rabbits. 
The lack of inhibition of either enzyme assayed, at the various 
titers of the antisera, could be accounted for by several reasons. One, 
that the assays were not sufficiently sensitive enough to detect the de-
crease in the activity {rate) of the enzymes, or two, that antibodies to 
either Des or Ide were not produced. Since both enzymes employed in this 
research have been extensively utilized in this type of assay, it was 
decided to investigate the possibility that antibodies were not being 
TITER OF 
ANTISERA 
0* 
1 
1:1 
1:10 
1:100 
1:1000 
CONTROL** 
TABLE 6 
TITERING OF DESMOSINE ANTISERA 
FROM RABBIT 1 
LYSOZYME 
(liA/MliM·1G PROTEIN) 
1.36 :t 0.07 
1.66 :t 0.03 
1.69 :t 8.04 
1. 67 ± 0. 03 
1.65 ± 0.02 
1.68 ± 0.03 
1.63 :t 0.05 
G-6-PDASE 
CM/MIN/UNIT) 
1.22 :t 0.05 
1.52 ± 0.04 
1.?1 ± 0.03 
1.49 ± 0.06 
1. 53 ± 0.02 
1.50±0.03 
1.53 ± 0.04 
RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE-DESMOSINE CONJUGATES 
AT VARIOUS TITERS OF ANTISERA FROM RABBIT 1. 
ADMINISTERED 2.5 MG BSA-DESMOSINE CONJUGATE/INJECTION, 
* ASSAYED WITH APPROPRIATE BUFFER, REPLACING ANTISERA, 
**ASSAYED WITH SERA FROM UNTREATED RABBIT, 
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TITER OF 
ANTISERA 
0* 
1 
1:1 
1:10 
1:100 
1:1000 
TABLE 7 
TITERING OF DESMOSINE ANTISERA 
FROM RABBIT 3 
LYSOZYME 
<~A/MIN/MG PROTEIN) 
' 
1. 36 :!: 0. 07 
1.69 :!: 0.05 
1.65 :!: 0.03 
1.67:!: 0.03 
1.68 :!: 0.04 
1.65:!: 0.03 
CONTROL** 1. 66 :!: 0.06 
G-6-PDASE 
(t.A/MIN/UNIT) 
1.22 :!: 0.05 
1.54 :!: 0.05 
1.58 :!: 0.04 
1.58 :!: 0.06 
1.56 :!: 0.02 
1.52 :!: 0.03 
1.52 :!: 0.04 
RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE- DESMOSINE CONJUGATES 
AT VARIOUS TITERS OF ANTISERA FROM RABBIT 1. 
ADMINISTERED 5,0 MG BSA-DESMOSINE CONJUGATE/INJECTION 
* ASSAYED WITH APPROPRIATE BUFFER~ REPLACING ANTISERA. 
** ASSAYED WITH SERA FROM UNTREATED RABBIT, 
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TITER OF 
ANTISERA 
o· 
1 
1:1 
1:10 
1:100 
1:1000 
TABLE 8 
TITERING OF ISODESMOSINE ANTISERA 
FROM RABBIT 5 
LYSOZYME 
(6A/MIN/MG PROTEIN) 
1.36 ± 0.07 
1. 64 ± a. 03 
1.67 ± 0.04 
1. 60 :!: 0.05 
1.65 ± 0.03 
1. 63 :!: 0. 04 
CONTROL** 1.64 :!: 0.02 
G-6-PDASE 
(6A/M1N/UNIT) 
1.22 ± 0.05 
1.45 :!: 0.04 
1.43 :!: 0.07 
1.48 :!: 0.06 
1. 45 :!: 0.03 
1.44:!: 0.04 
1.46 ± 0.03 
RATE OF REACTION FOR LYSOZYME- AND 6-6-PDASE-ISODESMOSIN~ 
CONJUGATE AT VARIOUS TITERS OF ANTISERA FROM RABBIT 5, 
ADMINISTERED 2.5 MG BSA-ISODESMOSINE CONJUGATE/INJECTION, 
* ASSAYED WITH APPROPRIATE BUFFER1 REPLACING ANTISERA, 
** ASSAYED WITH SERA FROM UNTREATED RABBIT, 
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TITER OF 
ANTISERA 
0* 
1 
1:1 
1:10 
1:100 
1:1000 
TABLE 9 
TITERING OF ISODES~10SINE ANTISERA 
FROM RABBIT 7 
LYSOZYME G-6-PDASE 
(~A/MIN/MG PROTEIN) ( M/MIN/UN IT) 
1.36 ± 0.07 1.22 ± 0.05 
1.56 ± 0.05 1.40 ± 0.03 
1. 50 ± 0. 04 1.38 ± 0.04 
1.55 ± 0.06 1.42 ± 0.02 
1.52 ± 0.05 1.40 ± 0.05 
1.50 :t 0.03 1.41 :t 0.03 
CONTROL** 1.53 ± 0.04 1.40 ±. 0.06 
RATE OF REACTION FOR LYSOZYME- AND G-6-PDASE-ISODESMOSINE 
CONJUGATES AT VARIOUS TITERS OF ANTISERA FROM RABBIT 7, 
ADMINISTERED 5,0 MG BSA-ISODESMOSINE CONJUGATE/INJECTION 
* ASSAYED WITH APPROPRIATE BUFFER, REPLACING ANTISERA, 
** ASSAYED WITH SERA FROM UNTREATED RABBIT, 
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produced to either Des or Ide. 
Immunodiffusion Studies: 
In order to determine if in fact antibodies were being produced to 
the desmosines, immunodiffusion studies were undertaken. In this tech-
nique, six wells are punched in a 1% agarose gel film, in a hexagonal 
shape, with a seventh well punched in the center of the hexagon. The 
antisera is placed in the center well, while the antigens are placed in 
the surrounding wells. As the solutions diffuse through the agarose, 
they eventually interface with each other. At the interface between the 
antisera and its specific antigen, a precipitin band will be observed, 
due to the antigen-antibody complex which is formed. 
In this study, prepared immunodiffusion plates {Travenol, 1% aga-
rose, containing 0.1% sodium azide to retard bacterial growth) were uti-
lized. The various titers of each antisera were placed into the center 
well, while the outer wells contained solutions of the various possible 
antigens. To one well, a 10% solution of BSA was added, while to another 
well, either BSA-Des or BSA-Ide was added, depending on the antisera in 
the center well. To the third well, the corresponding G-6-PDase-Des or 
-Ide conjugate was added. Finally the corresponding lysozyme-Des or 
-Ide conjugate was added. The plates were allowed to incubate at 5 °C 
for periods up to 1 week, with daily observation. 
It was observed that precipitin bands formed at all titers investi-
gated (1:1, 1:10, and 1:100, antisera in 0.9% sterile saline) to the 10% 
BSA solution, as well as the BSA-conjugates, within 1 days incubation. 
No precipitin bands were observed between the antisera and the corres-
pending enzyme conjugates by the end of the fifth day. 
In order to determine if the two buffers utilized in the enzyme 
assays had an effect on the antigen-antibody complex formation, the ex-
periment was repeated using the corresponding enzyme buffers in lieu of 
the 0.9% sterile saline solution used to prepare the various titers of 
the antisera. The results were essentially the same, precipitin bands 
were formed between all titers of the antisera to the BSA solution or 
the BSA-conjugates. Again, however, no precipitin bands were observed 
between the antisera and its respective enzyme conjugate. 
In both of the immunodiffusion studies, untreated rabbit sera was 
run as a control, and in all cases, no precipitin bands were formed be-
tween any of the solutions during the 5 day incubation preiod. 
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From these results it was concluded that antibodies were being pro-
duced to BSA, however, no evidence existed that antibodies to enzyme 
conjugates were being produced. These results implied that antibodies 
to Des or Ide were not being produced by the rabbits. 
Conjugation Studies: 
The results from the previous study, i.e., the production of anti-
bodies to BSA, while no apparent antibody production to Des or Ide, could 
be explained by the failure to conjugate the desmosines to the BSA mole-
cule. This occurence would also explain the large amount of unreacted 
Des or Ide eluted from the Sephadex G-50 column following conjugation. 
Therefore, in order to determine if this situation existed, Des was con-
jugated to BSA in the manner previously described, maintaining the Des to 
BSA ratio of 60, and varying the glutaraldehyde to Des ratio from 0 to 4. 
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Following the conjugation reaction, the conjugate was separated into its 
two fractions via gel filtration, both fractions being collected. The 
first fraction (presumptive conjugate) plus any precipitate formed during 
the conjugation reaction was collected and hydrolyzed as previously de-
scribed. The hydrolysates were then analyzed for their amino acid com-
position, as was the second fraction eluted from the column. Table 10 
displays the results from these studies, and as can be observed, no Des 
was detected in the first fraction at any of the Glu to Des ratios inves-
tigated, and that the amount of Des recovered from the second fraction 
did not significantly differ from the control reaction (Glu to Des = 0). 
From these results it was concluded that Des or Ide, in amounts 
capable of being detected by automated amino acid analysis, were not 
being conjugated to the BSA molecule at the glutaraldehyde to Des or Ide 
ratio utilized in the initial preparation of the conjugates. 
3H-Isodesmosine Conjugation Study: 
In the event that the amino acid analyzer was not sensitive enough 
to detect the amount of Des or Ide being conjugated to the BSA molecule, 
a radiolabeled tracer (3H-isodesmosine) was utilized in a conjugation re-
action. The labeled isodesmosine was reacted with the BSA as described 
in the methods, and following the conjugation, the amount of 3H-label in-
corporated into the BSA molecule was determined by liquid scintillation 
counting. 
At a glutaraldehyde to Ide ratio of 1, the ratio employed in the 
initial conjugation reactions, no activity above background could be 
detected in the first fraction off the column, while the second fraction 
TABLE 10 
DESr10SINE CONJUGATED TO BSA AT 
VARIOUS GLUTARALDEHYDE TO DESMOSINE PATIOS 
GLU/DES MOLE DES/f·10LE BSA DES RECOVERED *** 
CONTROL* 0 0 
0** 0 0.043 MMOLE 
1 0 0.043 MMOLE 
2 0 0.042 MMOLE 
3 0 0.043 MMOLE 
DETERMINATION OF THE AMOUNT DESMOSINE CONJUGATED TO BSA AT VARIOUS 
GLUTARALDEHYDE TO DESMOSINE RATIOS BY METHOD PREVIOUSLY DESCRIBED, 
DESMOSINE DETERMINED BY AMINO ACID ANALYSIS, 
.. 
•• 
.... 
fiFTY MG BSA HYDROLYZED AND ANALYZED, 
As IN CONJUGATION REACTION WITHOUT ADDITION OF GLUTARALDEHYDE, 
DETERMINED FROM DESMOSINE FRACTION FROM SEPHADEX G-50 COLUMN • 
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collected contained significant activity. 
From this qualitative study, when combined with the other conjuga-
tion studies, it was determined that at the glutaraldehyde to Des or Ide 
ratio utilized in this project, the two derived amino acids were not 
being conjugated to BSA, and consequently not producing antibodies. 
HPLC STUDIES 
Due to the inability to produce antibodies for use in an EIA for 
the desmosines, alternative methods of quantitation were investigated. 
These methods utilized high performance liquid chromatography, specifi-
cally, ion-exchange, reverse phase, reverse phase with ion suppression, 
and ion-pairing for the separation and quantitation of the desmosines. 
Ion-Exchange HPLC: 
The first technique investigated for the separation and quantitation 
of the desmosines was ion-exchange HPLC, due to its similarity to auto-
mated amino acid analysis (AAA). However, in contrast to AAA, which uses 
several buffers to elute the amino acids, this HPLC system uses only one 
buffer to elute all the amino acids (isocratic). 
Initial attempts to separate the desmosines from the other amino 
acids used a system which consisted of 0.2 mol/L ammonium phosphate buf-
fer, pH 3.5, with the eluted amino acids detected at either 205 or 254 
nm. A representitive chromatogram of an amino acid standard containing 
Trp, Phe, and Des is shown in Fig. 10. With this system, the 3 amino 
acids separated from one another, Trp eluting first, followed by Phe and 
Des. However, when a mixture of Des and Ide was injected, the two amino 
nnin. 
Fig. 10. Cation exchange HPLC separation of amino acid 
standard containing Trp, Phe, and Des. Stan-
dards eluted with 0.2 mol/L ammonium phosphate 
buffer, pH 3.5, and detected at 254 nm. 
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TABLE 11 
K' VALUES OF VARIOUS AMINO ACIDS AT PH 3,5 AND 2.5 
USING ION-EXCHANGE HPLC 
ArliNO ACID 
PH 3.5 PH 2.5 
K' K' 
TYR •• 0.25 
ALA ** 0.28 
TRP 0.52 0.68 
LEU •• 1.03 
lLE •• 1.03 
PHE 0.90 1.21 
DEs 1.50 1.97 
IDE 1.50 1.97 
K' DETERMINED FOR VARIOUS AMINO ACIDS USING JON-EXCHANGE HPLC ANALYSIS 
WITH A MOBILE PHASE OF 0.2 MOLfL AMt-IONIUM PHOSPHATE BUFFER, PH 3.5 AND 
2.5, WITH A FLOW RATE OF 0.7 MLIMIN (300 PSIG), AMINO ACIDS DETECTED 
AT 205 AND 254 NM, 
* TEN MG OF AMINO ACID DISSOLVED IN 50 ML OF 0.01 MOLIL KQH. 
INJECTION VOLUME OF 5 pl. 
•• Nor DETERMINED, 
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acids failed to separate. This result was further verified by injecting 
single amino acid standards of Trp, Phe, Des, and Ide, and determining 
their respective k' values. The k' values for Trp, Phe, and Des; or Trp, 
Phe, and Ide were sufficiently different such that they could be quanti-
tated (Table 11). However, the k' values for Des and Ide were identical, 
making it impossible to accurately quantitate them in a mixture. 
In an attempt to separate the desmosines, the pH of the mobile phase 
was lowered to 2.5, and again a series of amino acid standards were in-
jected. With this modified system, the k' values of the amino acids in-
creased from those obtained initially, and other amino acids were now 
resolvable (Tyr, Ala, Leu, or Ile). However, Des and Ide were still un-
resolvable, as was Leu and Ile (Table 11). 
From these results, it was concluded that although Des and Ide could 
be separated from various other amino acids, it was not possible to sep-
arate the two utilizing either of the two isocratic elution schemes dis-
cribed. These results were also confirmed by Farris and co-workers, when 
they failed to separate Des form Ide utilizing a similar ion-exchange 
system 118. 
Reverse Phase HPLC: 
Since the desmosines were found to be unresolvable with either of 
the isocratic, ion-exchange systems described, another separation tech-
nique was investigated. Reverse phase HPLC encompasses 3 different me-
thods of separation, all of which rely on the interaction between the 
organic characteristics of the analytes and the octadecyl (C-18) column. 
The first method investigated utilized a system which would separate 
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the desmosines without any enhancement of their organic nature. This 
system consisted of a methanol/phosphoric acid/water (30/1/69, v/v) buf-
fer, pH 5.85. The eluted amino acids were detected at either 205 or 254 
nm. A representitive chromatogram of a standard containing Des, Phe, and 
Trp is shown in Fig. 11. With this system the 3 amino acids were found 
to elute in reverse order from the ion-exchange system (Des, Phe, and 
Trp), and with sufficiently different retention times to facilitate their 
quantitation. However, it was noted that Des eluted with the void volume 
of the column, and that when a mixture of Des and Ide was injected, they 
both eluted with the void volume. These results were indicative of no 
interaction between the desmosines and the C-18 column (Table 12). 
Since the desmosines were eluting unresolved with the void volume 
of the column, it was attempted to increase their interaction with the 
column by lowering the methanol percentage of the mobile phase to 10%. 
This modification should allow for more hydrophobic interactions to 
occur between the desmosines and the column. It was found that while 
this modification of the mobile phase did increase the k' values of the 
other various amino acids, though not substantially, Des and Ide still 
eluted with the void volume (Table 12). 
Reverse Phase-Ion Suppression HPLC Studies: 
With the failure to resolve the desmosines with a lowering of the 
methanol percentage in the mobile phase, it was decided to decrease their 
polarity by partially suppressing their ionic nature. With this ion sup-
pression, the desmosines should interact with the C-18 moieties of the 
column more effectively. Therefore, the pH of the mobile phase was 
~ 
~ 
~ 
~ E < ~ 
U) ~ 
q U) 
0 ~ 
~ 
~ 
~ 
6 
min. 
Fig. 11. Reverse phase HPLC separation of amino acid standard 
containing Trp, Phe, and Des. Standards eluted with 
a mobile phase consisting of methanol/water/phosphoric 
acid (30/69/1, v/v/v) and detected at 254 nm. 
73 
TABLE 12 
K' VALUES OF VARIOUS AMINO ACIDS 
ELUTED WITH 30 AND 10 % r·1ETHANOL 
USING REVERSE PHASE HPLC 
30% 
N1!NO ACID* K' 
DEs 0.00 
IDE 0.00 
PHE 0.66 
TRP 1.11 
10% 
K' 
0.00 
0.00 
0.72 
1.20 
K' DETERMINED FOR VARIOUS AMINO ACIDS USING REVERSE PHASE HPLC ANALYSIS 
WITH A MOBILE PHASE OF METHANOL/PHOSPHORIC ACID/WATER (30/1/69 AND 
10/1/89, v/v), PH 5.35, WITH A FLOW RATE OF 1 MLIMIN. AMINO ACIDS 
DETECTED AT 254 NM, 
* TEN MG AMINO ACID DISSOLVED IN 50 ML OF WATER. 
INJECTION VOLUME OF 5 pL. 
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to 2.5, a pH at which several of the carboxyl functions on the desmosines 
would be protonated, thereby decreasing their polarity. To further en-
hance their interaction with the column, the methanol was entirely re-
moved from the mobile phase. 
Amino acid standards of Des, Ide, Phe, and Trp were then injected 
and eluted with this modified mobile phase of water/phosphoric acid 
(99/1, v/v), pH 2.5 (Table 13). It was found that, though the k' values 
of Phe and Trp did substantually increase, Des and Ide still eluted with 
the void volume of the column. 
From the results of the reverse phase and ion-suppression studies, 
it was concluded that although the desmosines were found to separate from 
other various amino acids using these particular systems, the desmosines 
themselves were still unresolvable. 
Reverse Phase with OPA Derivatization: 
From the previous studies it was determined that the polarity of the 
desmosines would have to be further reduced in order to achieve any type 
of separation between the two. One method which should substantially 
decrease their polarity would be to chemically modify the molecule. This 
modification could be accomplished by derivatizing the desmosines with a 
fluorogenic compound, such as OPA. This derivatization would not only 
enhance their interaction with the C-18 moieties, but also aid in their 
detection by being fluorescent. 
The OPA derivatized amino acids were initially eluted with a mobile 
phase consisting of 0.05 mol/L sodium phosphate buffer/methanol (50/50, 
v/v), pH 7.3, and detected by fluorescence emission at 405 nm. A repre-
TABLE 13 
K' VALUES OF VARIOUS AMINO ACIDS 
USING ION SUPPRESSION HPLC 
A11 I NO AC ID* 
DEs 
IDE 
PHE 
TRP 
K' 
0.00 
0.00 
1.16 
2.02 
K' DETERMINED FOR THE VARIOUS AMINO ACIDS USING REVERSE PHASE-ION 
SUPPRESSION HPLC ANALYSIS, WITH A MOBILE PHASE OF WATER/PHOSPHORIC 
ACID (99/l, v/v), PH 2,5, AT A FLOW RATE OF 1.0 MLIMIN, THE AMINO 
ACIDS WERE DETECTED AT 254 NM, 
* TEN MG AMINO ACID DISSOLVED IN 50 ML OF WATER, 
INJECTION VOLUME OF 5 pL. 
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sentative chromatogram of an amino acid standard is shown in Fig. 12. 
It was found that several of the derivatized amino acids were resol-
vable from one another. However, upon injection of derivatized Des or 
Ide no peaks were detected. It was initially thought that since the des-
mosines contained 4 amino groups available for derivatization with OPA, 
they could be retained by the column longer than 30 min. Therefore, it 
was decided to increase the methanol percentage of the mobile phase to 
70% in order to decrease their retention time. 
Fig. 13 is a representative chromatogram of the same amino acid 
standard as previuosly injected, this time eluted with the modified mo-
bile phase containing 70% methanol. ~·lith this modification it was found 
that all the derivatized amino acids eluted within 10 min, decreasing 
their retention times by approximately one third. Again, however, Des 
. 
and Ide were not detected. Finally, the methanol percentage was increas-
ed to 90%, and the same amino acid standards injected. With this in-
crease in the methanol percentage, it was found that all the amino acids 
eluted within 1 min, yet Des and Ide were still undetected. 
After reviewing the results from the derivatization method, it was 
discovered that Des and Ide were eluting close to the void volume of the 
column, and appeared as multiple peaks on the chromatogram. Multiple 
peaks could result from the 4 amino groups having different reactivities 
with the OPA. Similar results have been reported for dibasic amino acids 
with OPA derivatization by Lindroth and r1opper 105 . 
As the desmosines were found to elute in several fractions with the 
OPA derivatization method, and as the desmosines were unresolvable using 
the other reverse phase methods described, it was decided to attempt 
40 
minutes 
Fig. 12. Reverse phase HPLC separation of amino acid standard 
containing His, Tyr, Leu, Ile, Phe, Arg, Lys, Ide, 
and Des pre-derivatized with OPA. Standard eluted 
with 0.05 mol/L sodium phosphate buffer/methanol 
(50/50, v/v), pH 7.3, and detected by fluorescence 
(340 nm excitation; 450 nm emission). 
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Fig. 13. Reverse phase HPLC separation of amino acid standard 
containing His, Tyr, Leu, Ile, Phe, Arg, Lys, Ide and 
Des pre-derivatized with OPA. Standard eluted with 
0.05 mol/L sodium phosphate buffer/methanol (30/70, 
v/v), pH 7.3, and detected by fluorescence (340 nm ex-
citation; 450 nm emission). 
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their separation by ion-paired HPLC. 
Ion-Paired HPLC: 
Ion-paired HPLC utilizes a counter ion to one of the ionic species 
present on the molecules to be separated 119 . It was decided to use a 
counter ion to protonated amino groups which could be generated on the 
desmosines. This would require the mobile phase to be acidic, an en-
vironment suitable for the C-18 column. The counter ion chosen for this 
method was the sodium salt of heptane sulfonic acid, due to its wide-
spread use in ion-paired systems, and its general availability 119 . 
The concentration of the counter ion in most ion-paired systems vary 
from 0.005 mol/L to 0.02 mol/L. For this method of separation, knowing 
that hydrolysates were to be used, it was decided initially to use a con-
centration of 0.01 mol/L. 
Thus the ion-paired system utilized a methanol/water mobile phase, 
containing 0.01 mol/L sodium heptane sulfonate at an acid pH. Initially, 
a pH of 3 was used because at this pH several of the amino groups of the 
desmosines were protonated. Also, at this pH, minimal deterioration of 
the column occurs (optimal pH range for C-18 columns is between 2.5 and 
7.0) 12 , 119. The eluted amino acids were detected at 205 nm, therefore, 
the pH of the mobile phase was adjusted with phosphoric acid 104 . 
With this system, it was found that many amino acids could be sep-
arated from one another, including the desmosines. It was also found 
that by varying the methanol percentage of the mobile phase, the reten-
tion times of the amino acids could be varied. With this knowledge, it 
was decided to use a methanol percentage which would yield minimum 
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retention times for the desmosines, yet allow their separation. Thus in 
these preliminary studies, the methanol percentage of the mobile phase 
was varied from 10 to 30%. 
Initial attempts of the separation of the desmosines proved fruit-
ful, in that it was found that the desmosines could be resolved using 
this ion-paired system. Finally, it was determined that by using a sys-
tem consisting of methanol/water (26/74, v/v), pH 3.0, containing 0.01 
mol/L heptane sulfonic acid, baseline resolution of the two desmosines 
could be achieved. With this method, Ide and Des were found to elute at 
57 and 62 min, respectively, having k1 values of 50.80 and 57.33. 
Once it was determined that the desmosines could be resolved, other 
amino acids were investigated to determine if they would interfere. 
These amino acids were then injected and their k1 values determined 
(Table 14). It was found that from this series of 25 amino acids, all of 
which could possibly be present in the hydrolysates to be analyzed, none 
eluted close to either Ide or Des, the closest being Trp with a k1 value 
of 22.00. Tryptophan, however, should be destroyed in the acid hydroly-
sis procedure, thereby separating the desmosines from the other amino 
acids by approximately 30 min. 
Once it was determined that the method would reproducibly separate 
the desmosines from the other amino acids, the various chromatographic 
constants (k•, a, Rs' and N) of the method were investigated (Table 15). 
As previously described in Chapter 2, the capacity factor, k1 , is a 
measure of the retention of a particular solute by the system. Though 
usually, in the interest of time, the k1 values are kept below 10, in 
the case of the desmosines, the k1 values were approximately 5 times 
TABLE 14 
K' VALUES FOR VARIOUS AMINO ACIDS USING ION-PAIRED HPLC 
AMINO ACID K' 
HYDROXYPROLINE 0.56 
PROLINE 0.76 
CYSTEINE 0.81 
GLYCINE 1.10 
ALANINE 1.12 
GLUTAMIC ACID 1.25 
GLUTAMINE 1.30 
SERINE 1.30 
THREONINE 1.35 
AsPARTIc AcID 1.42 
AsPARAGINE 1.44 
VALINE 3.40 
ORNITHINE 5.96 
HYDROXYLYSINE 6.36 
LYSINE 6.92 
TYROSINE 7.25 
HISTIDINE 7.47 
IsoLEUCINE 7.60 
LEUCINE 8.80 
ARGININE 8.85 
NoRLEUCINE 9.00 
PHENYLALANINE 9.80 
TRYPTOPHAN 22.00 
IsoDESMOSINE 50.80 
DESMOSINE 57.33 
k' values of various amino acid standards, calculated as 
described in Chapter 2. Amino acids eluted with methanol/ 
water (26/74, v/v), pH 3.0, containing 0.01 mol/L heptane 
sulfonic acid, and detected at 205 nm. 
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TABLE 15 
CHRONATOGRAPHIC CONSTANTS FOR DESMOSINE 
AND ISODESMOSINE SEPARATION USING 
ION-PAIRED HPLC 
K' Rs 
IDE DES 
N 
IDE DEs (HETP)* (HETP) 
50.80 57.32 1.13 4.80 29J026 25J600 
(0.001) (0.001) 
VARIOUS CHROMATOGRAPHIC CONSTANTS DETERMINED FROM DES AND IDE 
STANDARDSJ ELUTED WITH A MOBILE PHASE OF METHANOL/WATER (26/74J 
v/v)J PH 3.0J WITH A FLOW RATE OF 1.0 ML/MIN, 
AMINO ACID DETECTION AT 205 NM, 
CONSTANTS CALCULATED AS DESCRIBED IN CHAPTER 2. 
* HEIGHT EQUIVALENT TO THEORETICAL PLATES. 
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that value. In an attempt to lower the k1 values for the desmosines 
either by increasing the methanol percentage in the mobile phase, or by 
adjusting the pH, the resolution of the two amino acids decreased. 
Therefore, it was decided not to adjust the k1 values. 
Although the k1 values of Des and Ide were higher than usual, the 
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separation factor, a, was found to be in an acceptable range. This fac-
tor, as described in Chapter 2, is actually a measure of the relative re-
tention of Des and Ide, and is related to the chemical parameters of the 
method. By definition, this factor should be greater than 1.00, and 
since the factor utilizing this method of separation was greater than 
1.3, modifications were not necessary 119. 
The efficiency (N) of the C-18 column to separate the desmosines was 
found to be excellent, both having theoretical plate values exceeding 
25,000. Though these values are somewhat higher than those usually en-
countered in an HPLC method, this can be explained by the long retention 
times of the desmosines and their relatively narrow peak width on elution 
119 
Another measure of the efficiency of the column to separate the 
analytes is the height equivalent to theoretical plates (HETP), sometimes 
abbreviated H 119. This value is simply the column length in em divided 
by the efficiency factor, N. For this constant, the better the effi-
ciency, the lower the H value, just opposite to the definition for the 
N factor. 
Finally, the ability of this method to resolve the desmosines was 
determined. The factor, Rs, should be greater than 1 for quantitation, 
and greater than 1.5 for baseline resolution 119 As described in 
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Chapter 2, this factor takes into account all the other calculated con-
stants determined for that specific system. Thus, Rs is a measure of 
the selectivity of the column for the analytes (as determined by the a 
factor); secondly, it takes into account the efficiency of the column for 
the analytes (as determined by theN factor); and thirdly, it takes into 
account the capacity of the system for the analytes (as determined by 
ki)· 
Utilizing this method for the separation of the desmosines, the Rs 
value was in excess of 4, indicating, for the amount of time on the col-
umn, the separation of the two eluted amino acids approached the base-
line. Thus, the desmosines should be able to be quantitated by this 
method with no interference from the other amino acids, or themselves. 
Method Parameters: 
As previously stated, a is a term which is dependent on the chemical 
interactions of the analytes with the system. Therefore, it was decided 
to investigate several of the chemical parameters of the method, and de-
termine their effects on the separation of the desmosines. The first 
parameter investigated was the effect of the methanol percentage of the 
mobile phase on the separation of the desmosines. In the initial deve-
lopment of the method, the methanol percentage was varied to achieve max-
imum separation of the desmosines. Qualitatively, as the methanol per-
centage increased, the retention times of the desmosines decreased, as 
did their resolution. Thus as the methanol increased, N, a, and R5 de-
creased. It was found that above a methanol percentage of 30, the effi-
ciency (N) decreased drastically as did the separation factor, a, which 
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decreased to 1. The Rs was also found to decrease from 4.8 with 26% me-
thanol to less than 1 with a percentage above 36%. In all cases, the 
methanol percentage yielding maximal chromatographic characteristics was 
determined to be between 25 and 28%. 
It was also found that as the column aged, the retention times of 
the desmosines decreased. In order to offset this decrease, the concen-
tration of the methanol was lowered. The decrease in the retention time 
by the column is believed due to deterioration of the column with usage 
119 Finally, it was noted that as the methanol percentage increased, 
the column head pressure also increased. 
The next chemical parameter investigated was the effect of the mo-
bile phase pH on the separation of the desmosines. From these studies, 
it was determined that as the pH increased above 3.0, the k1 values of 
the amino acids decreased (Fig. 14). It was noted that the desmosines 
could effectively be separated up to a pH of approximately 3.2; however, 
several of the other amino acids could not be resolved at this pH. It 
was also found that if the pH was decreased below 3.0, no substantial 
effects were observed. Therefore, it was decided to maintain the pH at 
3.0. 
From these studies it was determined that the pH decreased the value 
of N, a, and Rs constants, similar to increasing the methanol concentra-
tion. These interactions are believed due to the amount of ionization 
of the amine groups on the amino acids with the sulfonic acid residues 
of the counter ion 119 . 
. Finally, the effect of the counter ion concentration was investiga-
ted. With ion-paired systems, the solvent strength can be varied by 
k' 
o.o;-------r--------,-------,...-------. 
3.0 3.2 3.4 3.6 3.8 
pH 
Fig. 14. Effect of ion-paired mobile phase pH on k' values of 
several amino acid standards. Mobile phase consisted 
of methanol/water (26/74, v/v), containing 0.01 mol/L 
heptane sulfonic acid, with the pH varied from 3.0 to 
3.8. 
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changing the counter ion concentration 119 . Thus, by increasing the con-
centration of the counter ion in the mobile phase, the k' values of the 
analytes can be increased, if the analyte is not fully ionized 119 . 
Therefore, a change would be expected in a. If however, the analyte is 
fully ionized, little or no change should be observed in a. 
When the heptane sulfonic acid concentration was increased to 0.02 
mol/L, a very small increase was noticed in the k' values of the desmo-
sines. However, no change was observed in the a factor. If the concen-
tration was decreased, both Des and Ide k' values were found to decrease, 
substantually decreasing a. Therefore, for this method it was decided 
to maintain the heptane sulfonic acid concentration at 0.01 mol/L. 
Quantitation of the Desmosines: 
Once it was determined that the method would reproducibly separate 
the desmosines from one another and other amino acids, their quantitation 
was attempted. In order to access their ability to be quantitated, a 
standard curve was constructed, as described in Chapter 3. Essentially, 
various concentrations of Des and Ide standards were injected separately 
and together, such that any deviations, with their simultaneous quanti-
tation, would be detected. 
Desmosine and Ide were found to display a linear response to the 
various concentrations injected, both singly and together, when detec-
ted at 205 nm (Figs. 15, 16; circles). Upon analysis of the curve, Des 
and Ide yielded almost identical equations of the lines (y = 68.28x + 
0.04 for Des, andy= 64.55x - 0.07 for Ide). Not only did both amino 
acids display similar slopes and y-intercepts, they were found to display 
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Fig. 15. Standard curve (0} and recovery from hydrolyzed BSA (~) 
of desmosine using the ion-paired HPLC method. 
(0) Known concentrations of purified desmosine standards 
injected and peak heights determined. 
(~) Known concentrations of purified desmosine standards 
added to BSA prior to hydrolysis. Recovery peak 
heights compared to standard curve peak heights. 
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Fig. 16. Standard curve (0) and recovery from hydrolyzed BSA (~) 
of isodesmosine using the ion-paired HPLC method. 
(0) Known concentrations of purified isodesmosine standard 
injected and peak heights determined. 
(~) Known concentrations of purified isodesmosine standards 
added to BSA prior to hydrolysis. Recovery peak 
heights compared to standard curve peak heights. 
excellent correlation between their respective concentrations and peak 
heights (r greater than 0.99 for both). 
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Once it was determined that the desmosines could be quantitated at 
205 nm, various other wavelengths were used in their detection. Again, 
the peak height was used as the measure of quantitation. Initailly, the 
wavelength was decreased in order to increase the sensitivity of the 
detection. However, it was found that as the wavelength decreased the 
baseline absorbance increased, such that the desmosines were undetec-
table. This effect was due to the methanol in the mobile phase, as me-
thanol has been shown to have an absorbance cutoff at 205 nm. 
When the wavelength was increased, the sensitivity for the detection 
of the desmosines decreased. While this decrease was not substantial 
(approximately 10% at 215 nm), it was considered significant. Therefore, 
the desmosines were detected at 205 nm, as previously described. 
From these studies it was concluded that not only would this system 
separate the desmosines, but would simultaneously quantitate Des and Ide. 
Once it was determined that the desmosines could be quantitated, the 
reproducibility of the method was investigated. For this precision 
study,standards of Des and Ide (0.0851 and 0.0569 mmol/L, respectively) 
were injected according to two schedules. For the intra-day precision, 
Des and Ide were injected 10 times daily, while for the inter-day preci-
sion, Des and Ide were injected once daily for 10 days. In all cases, 
the peak heights were determined and used in the calculations. 
It was found that the standard deviations (S.D.) and the coeffi-
cients of variation (C.V.) were less than 0.2 em and 3%, respectively, 
for both the intra- and inter-day precision studies (Table 16). It was 
TABLE 16 
INTRA- AND INTER-DAY PRECISION STUDIES 
FOR DESMOSINE AND ISODESMOSINE DETERMINATIONS 
BY ION-PAIRED HPLC 
N=lO 
INTRA-DAY INTER-DAY 
DES IDE DES IDE 
PEAK HEIGHT (eM) 7.99 
0.07 
0.93 
3.98 
0.06 
1.58 
7.96 
0.14 
1.69 
3.79 
0.09 
2.39 
S.D. (eM) 
c.v. (%) 
DESMOSINE AND ISODESMOSINE STANDARDS (0.0851 AND 0,0569 MMOL/l 
INJECTED 10 TIMES PER DAY FOR INTRA-DAY PRECISION, AND ONCE 
DAILY FOR 10 DAYS FOR THE INTER-DAY PRECISION DETERMINATIONS, 
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also noted that the S.D. and the C.V. of the intra-day determinations 
were approximately one-half the inter-day determinations. This result 
is to be expected, as the within day precision is almost always greater 
than the between day precision 120 
A C.V. of less than 5% is usually acceptable for analytical deter-
minations 120. Therefore, with this method displaying a low C.V. for 
both the desmosines (less than 3%), it was concluded that it was well 
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within the acceptable limit of reproducibility for an analytical method. 
Recovery Studies: 
The final analytical parameter investigated was the percent recovery 
of Des and Ide from various samples, to demonstrate the accuracy of the 
method. The first study utilized BSA, a protein which contains no desmo-
sines. To this protein, Des and Ide were added, prehydrolysis, and the 
samples prepared as described in Chapter 3. 
Following the analysis of the hydrolysates, the Des and Ide concen-
trations were determined, and compared to their standard curves. Both 
Des and Ide were well within the peak heights for their respective spikes 
(Figs. 15, 16; triangles). The slope andy-intercept for both the Des 
and Ide spikes (y = 71.48x- 0.02 andy= 60.56x + 0.02, respectively), 
correlated well with the slopes and y-intercepts of the standard curves 
for Des and Ide (r = 0.99). The range of recovery for the Des spikes 
were between 98 and 102%, with an average recovery from the spiked BSA 
of 99.6%. The average recovery of Ide from spiked BSA was 98.5%, with a 
recovery range from 96 to 102%. 
Also, from this initial recovery study, the lower limit of detection 
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for either Des or Ide was approximately 100 pmol. Below this level, the 
desmosine peak was indistinguishable from the baseline noise of the de-
tector. 
Following the determination of the recoveries from a sample which 
contained no desmosines, a Des and Ide spike was added to a sample known 
to contain both the amino acids. For these studies, a canine aorta sam-
ple was obtained and prepared as described in Chapter 3. Again, the Des 
and Ide was added prior to the hydrolysis procedure. In this study, one 
sample of the aorta remained unspiked, while the remaining 5 samples were 
spiked with both Des and Ide. 
Upon analysis and determinations of the Des and Ide concentrations 
of the unspiked and spiked samples, the recoveries were calculated, and 
the observed values (ion-paired HPLC determinations) vs. the predicted 
values (calculated from the amount of the spike) were plotted. The re-
coveries for both Des and Ide were found to be excellent. The recovery 
range for Des was between 95 and 100%, with an average recovery of 97.2%. 
The recovery range for Ide was determined to be between 96 and 102%, with 
an average recovery of 99%. 
When the observed concentrations were compared to the predicted con-
centrations, both Des and Ide were found to display a linear relationship 
(Figs. 17, 18). Upon statistical analysis of the recoveries, both Des 
and Ide displayed similar slopes and y-intercepts (y = 0.99x + 0.002 for 
Des, andy= 0.95x + 0.003 for Ide), and were found to correlate well 
with their respective predicted values (r greater than 0.97 for both 
amino acids). 
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Fig. 17. Recovery of purified desmosine from hydrolyzed canine 
aorta as described in Chapter 3. Recovered (observed) 
concentrations plotted against the predicted concentra-
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Canine Aorta Studies: 
From all the previous analytical studies, the method was determined 
to be reproducible, accurate and precise for the separation and quanti-
tation of the desmosines 119 , 120. This having been established, it was 
decided to attempt to quantitate the desmosines, using tissue samples. 
The tissue to be investigated was canine aorta (aortic arch region). 
This tissue was chosen because the concentration of both the desmosines, 
as well as the elastin content, is well documented 101 , 121 - 123 In this 
study, the Des and Ide concentrations of the aorta samples, determined 
by ion-paired HPLC, were compared to those concentrations obtained by 
automated amino acid analysis (AAA). Finally , the elastin content of 
the canine aortas was estimated from the Des and Ide concentrations of 
the samples, and compared to the elastin content as determined by gravi-
metic procedure. 
Thirteen canine aortas were obtained and prepared as described in 
Chapter 3. Of the prepared, diluted hydrolysates, 10 ~L of each was in-
jected, and the desmosines quantitated as described by the ion-paired 
method. The desmosines were found to elute in a manner similar to the 
Ide and Des standards, with retention times of 52 and 57 min, respec-
tively (Fig. 19). The other amino acids present in the hydrolysates 
were also found to elute similar to their respective standards. In all 
the chromatograms of the aorta samples, one prominent peak was observed 
to elute between Phe and Ide, with a k' value different from any investi-
gated amino acid (31.50). This peak was thought to be lysinonorleucine, 
a minor cross-link found in elasti'n (see Chapter 1). 
The concentrations of Des and Ide were then calculated from their 
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Fig. 19. Representative ion-paired HPLC chromatogram of 
hydrolyzed canine aorta. Hydrolysate eluted with 
methanol/water (26/74, v/v) mobile phase, con-
taining 0.01 mol/L heptane sulfonic acid, pH 3.0. 
Detection at 205 nm. 
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respective standard curves, for each of the 13 canine tissue samples 
(Table 17). In a similar fashion, the Des and Ide concentrations of each 
of the 13 samples were determined by AAA, as previously described in 
Chapter 3 (Table 17). 
Once the Des and Ide concentrations were determined by both methods, 
the results were compared. Both Des and Ide were found to correlate well 
with the AAA, both having a linear relationship, with slopes of approxi-
mately one with small intercepts, and with correlation coefficients of 
greater than 0.97 (Figs. 20, 21). These results indicated that no sig-
nificant difference existed between the two methods of determination for 
Des and Ide (p<O.OOl). 
From this study it was concluded that Des and Ide concentrations 
could be determined from tissue samples using the ion-paired HPLC method, 
with no significant difference between the results obtained by ion-paired 
HPLC, and those obtained from the accepted method of AAA 124- 126 . 
Estimation of Elastin and Collagen Content of the Aorta: 
The elastin content of the aorta was estimated from the Des and Ide 
concentrations 39, 121 , 122 . For this estimation, it was initially nec-
essary to determine the percentage of the total desmosines (Des plus Ide) 
in elastin. In order to determine this percentage, the amino acid anal-
yses of purified elastins from human and canine aorta and lung were ob-
tained from several investigators 101 ,121- 123 . Lung elastin was included 
for several reasons: one, it has been shown that the amino acid content 
of purified elastin from aorta and lung are very similar; and secondly, 
the majority of recent publications on the purification and amino acid 
DOG 
1 
3 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
TABLE 17 
DESMOS I NE AND I SODESMOS I NE CGrlCENTRA T IONS 
AS DETERMINED BY HPLC AND AUTOMATED 
AMINO ACID ANALYSIS 
AUTOMATED 
AMINO ACID ANALYSIS 
DES (MMOLfL) IDE DEs 
0.406 0.305 0.441 
0.204 0.165 0.257 
0.123 0.097 0.117 
0.474 0.367 0.446 
0.310 0.256 0.280 
0.318 0.254 0.301 
0.348 0.295 0.341 
0.482 0.346 0.510 
0.267 0.256 0.289 
0.452 0.360 0.458 
0.338 0.290 0.360 
0.328 0.276 0.363 
0.516 O,t(S6 0.565 
HPLC 
(MMOLIL) IDE 
0.295 
0.184 
0.103 
0.360 
0.285 
0.293 
0.306 
0.361 
0.271 
0.344 
0.312 
0.297 
0.473 
DESMOSINE AND !SODESMOSINE CONCENTRATIONS OF 13 CANINE AORTA SAMPLES 
PREPARED AS DESCRIBED IN CHAPTER 3. 
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Fig. 21. Regression analysis of isodesmosine concentrations of 13 
hydrolyzed canine aortas as determined by AAA and ion-
paired HPLC. 
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content of elastin has utilized lung tissue 101 , 121- 123. 
Upon examination of the amino acid content of these elastin prepara-
tions, it was found that there are approximately 2-4 total desmosine 
residues per 1000 residues. Thus in order to determine the percent total 
desmosines in elastin, the molecular weight (~~) contribution of the 
total desmosines was divided by the total MW of the 1000 residues of 
elastin and then multiplyed by 100. 
From these determinations, it was found that approximately 1.3% of 
elastin is total desmosines, or for every mg elastin, 13 ~g is contri-
buted by the desmosines. To further substantiate the use of the purified 
lung elastin in the percentage determination, when the percent desmosines 
were calculated in the lung preparation only (not incorporating any data 
from the aorta), the percent was again found to be 1.3. 
. 
Thus for the elastin calculations, the Des and Ide concentrations 
were first converted from mmol/L to nmol total desmosines/mg aorta FFDW. 
The nmol total desmosines were converted to ~g total desmosines by the 
MW of the desmosines, yielding a ~g total desmosines/mg aorta FFDW. The 
elastin content was finally arrived at by using the conversion factor of 
13 ~g total desmosines per mg elastin. 
These calculations were performed on the Des and Ide results, ob-
tained by ion-paired HPLC and AAA, from the 13 canine aorta samples 
(Table 18). Upon statistical analysis, both methods were found to be in 
good agreement with one another, displaying a linear relationship (Fig. 
22), with a slope of approximately one (y = 0.91x +53), and an r value 
of 0.9326, indicating excellent correlation between the two methods 
(p<0.001). Also, no significant difference was found between the mean 
TABLE 18 
ELASTIN AND COLLAGEN CONTENT OF CANINE AORTA 
DOG % ELASTIN % COLLAGEN % CTP** AAA HPLC UNCORR~ CORR.* UNCORR.* CORR.* 
1 38.9 40.3 28.6 22.5 68.0 62.8 
2 30.9 37.1 46.9 41.3 84.0 78.4 
5 25.5 25.5 52.0 48.1 77.5 73.6 
6 IJ3,8 42.0 30.5 24.1 72.5 66.1 
7 38.5 38.5 27.4 20.7 65.9 59.2 
8 41.0 42.5 24.9 18.4 67.4 60.9 
9 44.8 45.0 21.2 14.3 66.2 59.3 
10 41.2 43.5 27.2 25.0 70.7 64.0 
11 31.3 34.9 30.4 25.0 65.3 59.9 
12 45.2 44.6 28.8 22.0 73.4 64.6 
13 LJ2, 5 LJ5 .LI 26.9 20.0 72.3 65.4 
14 37.8 1Jl.2 23.6 17.3 64.8 58,5 
15 46.2 50.9 29.0 21.3 79.9 72.2 
~------------- ·--· 
------------
ELASTIN AND COLLAGEN CONTENT (UNCORRECTED AND CORRECTED) CALCULATED AS DESCRIBED IN CHAPTER 4, 
* UNCORR ~ UNCORRECTEDj CORR. ; CORRECTED 
** % CTP; %CONNECTIVE TISSUE PROTEIN, AS DETERMINED BY PERCENT ELASTIN PLUS COLLAGEN. 
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Fig. 22. Regression analysis of elastin content of 13 canine 
aortas, calculated from Des and Ide concentrations as 
determined by AAA and ion-paired HPLC. 
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elastin content obtained from AAA (390.5 ± 63 mg elastin/g aorta FFDW) 
and the mean elastin content as determined by ion-paired HPLC (408.8 ± 
62 mg elastin/g aorta FFDW). 
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Once the elastin content had been calculated from the Des and Ide 
concentrations, it was decided to compare these results to the elastin 
content of the same canine aorta samples as determined by a gravimetric 
procedure. This method of elastin determination relied on the insolubi-
lity of the protein through several extractions including; a 1% sodium 
chloride extraction, followed by several autoclavings at 121 °C and 18 
psig, until the resulting supernatant was devoid of protein, and finally, 
the remaining residue was extracted with hot (100 °C) 0.1 mol/L sodium 
hydroxide to remove any remaining non-elastin proteins. The residue re-
maining following the alkali extraction was considered elastin 27 ,29 . 
This procedure was performed on 5 canine aorta samples, and the 
elastin content as determined by both methods (gravimetric and calcu-
lated) were compared. The average elastin content obtained by the cal-
culation method (408.7 ± 61 mg elastin/g aorta FFDW) was found to be 
somewhat higher than the elastin content as determined by the gravimetric 
procedure (325.1 ± 27.5 mg elastin/g aorta FFDW), though no significant 
difference between the two methods was noted. 
From this study it was determined that no significant difference 
existed between the gravimatric and calculation procedures for the esti-
mation of the elastin content of the canine aorta. This finding, how-
ever, may be biased by one result which yielded the same elastin content 
by both procedures. If this result was not included, a significant in-
crease was observed in the elastin content when dete~ined by HPLC. 
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Aorta Collagen Determinations: 
Though elastin has been shown to be a major component of the aorta, 
another major connective tissue protein, collagen, is also present. 
Therefore, in order to determine the total connective tissue protein con-
tent of the aorta, the collagen content of the aorta samples was deter-
mined. Collagen content is frequently estimated by the hydroxyproline 
(Hyp) content of the tissue, in a manner similar to the use of Des and 
Ide for the estimation of the elastin content 40 . Therefore, in order to 
determine the collagen content, the percent Hyp in collagen was deter-
mined. This determination was based on the amino acid analyses of vari-
ous purified collagen preparations 127-129 It was found that there were 
between 88 and 95 Hyp residues per 1000 residues of collagen. From this, 
the percent Hyp in collagen was calclated, by the previously described 
methods, to be 11.1%. Therefore, for every mg collagen, 111 ~g is con-
tributed by Hyp. 
Using this Hyp percentage, the collagen content of the 13 canine 
aorta samples were determined as described in Chapter ·3 (Table 18). It 
was found that the collagen content of the aortic samples varied from 20 
to 50%, with an average collagen content of 305.7 ± 110.6 mg collagen per 
g aorta FFDW. The total connective tissue protein content of the aorta 
samples were found to vary from 60 to 80% of the total weight, with an 
average of 700.0 mg total connective tissue protein/g aorta FFDW. During 
the course of this study it was noted that generally, as the elastin con-
tent increased, the collagen content decreased. 
As previously mentioned, the collagen content is derived from the 
quantitation of Hyp. However, other proteins, specifically elastin, have 
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been shown to contain Hyp 101 , 121 - 123 . Since it has been shown that the 
aorta contains a significant amount of elastin (approximately 40%), the 
Hyp from elastin is being included in the total amount of Hyp in the tis-
sue. Thus, non-collagen Hyp would tend to elevate the collagen levels 
in tissues which are rich in elastin. 
In order to determine if this apparent increase in the collagen con-
tent would be significant, the Hyp component of elastin was calculated 
by determining the percent Hyp in purified preparations of elastin. It 
was found that elastin contained approximately 1.7% by weight Hyp 101 , 
121-123 This non-collagen Hyp was then subtracted from the total Hyp 
and the collagen content was recalculated, to obtain a "corrected" col-
lagen content of the canine aortas (Table 18). Upon analysis of the 
"uncorrected" and "corrected" collagen content, it was found that the 
difference between the uncorrected and corrected values was significant 
(p<0.01), and that the corrected values were approximately 10% less than 
the uncorrected values. It was also noted that the largest apparent de-
crease in the collagen content occurred in samples which contained high 
percentages of elastin. 
As previously stated, it was found that as the elastin content of 
the aorta increased, the collagen content was found to decrease. When 
the various elastin and collagen percentages of the 13 canine aortas were 
plotted, an inverse relationship was, in fact, found to exist (Fig. 23). 
This relationship may be biased by the inclusion of two samples which 
were found to be high in collagen and low in elastin (Dogs 2 and 5). If 
these two samples were excluded from the population no relationship could 
be inferred. However, no justification existed for their exclusion, 
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Fig. 23. Relationship between elastin and collagen (corrected) 
content for canine and human aortic tissues. Elastin 
calculated from Des and Ide concentrations as determined 
by ion-paired HPLC. Collagen content calculated from 
corrected Hyp concentrations. 
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therefore, they were included in the population. 
Effect of Age on the Elastin and Collagen Content of Human Aortas: 
Having determined the validity of both the ion-paired HPLC method 
for the quantitation of the desmosines, and their subsequent use for the 
estimation of the elastin content, an investigation of the effect of age 
on both the elastin and collagen content of human aortic arch tissues was 
undertaken. For this study, samples of human aorta (aortic arch region) 
were obtained from eleven post-mortem examinations at Loyola University 
Medical Center. Only tissue that on gross examination by a pathologist 
appeared free of pathological processes were used in this study. The age 
and sex of each subject from whom the tissues were obtained were noted 
(Table 19). The all Caucasian population included 5 females and 6 males, 
ranging in ages from 2 to 90 years. 
Following the tissue preparation (as described in Chapter 3), the 
Des and Ide concentrations were determined by both the ion-paired HPLC 
method, and by AAA (Table 20). It was noted that the ion-paired HPLC 
chromatograms obtained from the human aorta hydrolysates were very simi-
lar to the chromatograms obtained from the canine hydrolysates, with Ide 
and Des eluting at 59 and 66 min, respectively (Fig. 24). 
Following the quantitation of the desmosines in the human aorta 
hydrolysates, the percent elastin in each was estimated as previously 
described in the canine aorta studies (Table 21). From these calcula-
tions, it was found that the results obtained from the ion-paired HPLC 
method again correlated well (r = 0.96) with the results obtained via the 
AAA, yielding a linear relationship between the two methods (y = 1.00x + 
SAMPLE 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
TABLE 19 
DEMOGRAPHICS OF HUMAN SAMPLES 
LAB # * SEX 
81A-21 , M 
81A-20 F 
81A-22 M 
81A-30 F 
81A-31 M 
81A-19 F 
81A-33 M 
81A-32 F 
81A-18 M 
81A-34 M 
81A-17 F 
AGE (YRS) 
2 
5 
17 
34 
58 
66 
66 
67 
70 
70 
90 
AGE AND SEX INFORMATION OF SAMPLES OBTAINED FROM HUMAN SUBJECTS, 
* lABORATORY ASSIGNED NUMBER, 
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TABLE 20 
DESMOSINE AND ISODESMOSINE CONCENTRATIONS OF HUMAN AORTIC ARCH 
TISSUES AS DETERMINED BY HPLC A~D AUTOMATED 
AMINO ACID ANALYSIS 
AUTOMATED 
SAMPLE AMINO ACID ANALYSIS HPLC 
DES (MMOLfL) IDE DEs (MMOLIL) IDE 
1 0.174 0.155 0.186 0.149 
2 0.114 0.119 0.139 0.113 
3 0.177 0.130 0.176 0.126 
4 0.123 0.103 0.118 0.088 
5 0.106 0.071 0.110 11,083 
6 0.131 0.088 0.132 0.098 
7 0.114 0.094 0.116 0,086 
8 0.102 0.062 0.109 0.083 
9 0.131 0.076 0.147 0.101 
10 0.117 0.095 0.116 0.094 
11 0.098 0.078 0.094 0.072 
DESMOSINE AND ISODESMOSINE CONCENTRATIONS OF HUMAN AORTIC ADCH 
SAMPLES PREPARED AS DESCRIBE IN CHAPTER 3, ALL SAMPLES RUN IN 
DUPLICATE, 
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Fig. 24. Representative ion-paired HPLC chromatogram of hydro-
lyzed human aorta. Hydrolysate eluted with methanol/ 
water (26/74, v/v) mobile phase containing 0.01 mol/L 
heptane sulfonic acid, pH 3.0. Detection at 205 nm. 
TABLE 21 
ELASTIN AND COLLAGEN CONTENT OF HUMAN AORTIC ARCH TISSUE 
% ELASTIN % COLLAGEN % CTP** SAMPLE 
AAA HPLC UNCORR.* CORR.* UNCORR.* CORR.* 
1 45.8 46.6 40.6 33.5 87.2 80.1 
2 31.2 35.1 44.7 39.5 79.8 74.6 
3 42.7 42.1 40.4 33.9 82,5 76.0 
4 31.5 28.6 31.2 25.1 59,8 53.7 
5 27.0 26.8 36,0 31.9 62,8 58.7 
6 24.6 26.9 37.0 32.9 63,9 59,8 
7 30.5 32,0 . 26.7 22.7 58,7 54.7 
8 28.4 27.8 33.1 28.9 60.9 56.7 
9 33.0 35.8 30,5 25.0 66,3 60,8 
10 29.5 30.4 32.7 28.0 63.1 58.4 
11 24.5 23.1 37,9 34.4 61.0 57,5 
ELASTIN AND COLLAGEN (UNCORRECTED AND CORRECTED) CONTENT CALCULATED AS DESCRIBED IN CHAPTER 4, 
• UNCORR. = UNCORRECTEDi CoRR, : CORRECTED 
** % CTP = % CONNECTIVE TISSUE PROTEIN~ AS DETERMINED BY PERCENT ELASTIN PLUS COLLAGEN, 
ELASTIN CONTENT DETERMINED FROM DES AND IDE QUANTITATION BY ION-PAIRED HPLC, 
....... 
....... 
.J::> 
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0.6). Therefore, the elastin content, as determined by the ion-paired 
HPLC quantitation of the desmosines was utilized in all further analyses 
of the human aorta samples. 
Upon statistical analysis of the human aorta samples, it was found 
that they segregated into two groups. The first group (age 2-17) had a 
mean elastin content of 412.6 ± 58.1 mg/g aorta FFDW, while the second 
group (age 34-90) was found to have a mean elastin content of 288.7 ± 
38.1 mg/g aorta FFDW. These two means were determined to be statisti-
cally different (p<0.01). From these results it was concluded that with 
age, the elastin content of the aorta (aortic arch region) decreased 
significantly. 
Following the determination of the elastin content of the human 
aorta samples, the collagen content of these same samples were deter-
mined, as previously described in the canine aorta study. Again, both 
the uncorrected and corrected collagen content of each sample was calcu-
lated (Table 21). 
Upon statistical analysis, it was found that the uncorrected colla-
gen content of the aorta samples were segregated into 2 age groups, iden-
tical to the age groups found in the elastin study. The first group (age 
2-17) had a mean collagen content of 419.0 ± 24.5 mg collagen/g aorta 
FFDW, while the second age group {34-90) was found to have a mean colla-
gen content of 331.2 ± 37.0 mg collagen/g aorta FFDW. These two means 
were found to be statistically different (p=0.05). However, when the 
correction for the non-collagen Hyp content of the aorta samples were 
made, and the corrected collagen content.determined, it was found that 
while the younger age group had a somewhat higher mean collagen content 
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than the older group (356.0 ± 34.4 mg collagen/g aorta FFDW vs. 286.9 ± 
45.5 mg collagen/g aorta FFDW), and that there was a decrease in the col-
lagen content from young to old, the significance observed in the uncor-
rected collagen diminished. This decreasing tendency in the collagen 
content of aortic samples with age has been observed by other investiga-
tors 134,135 
From these results it was concluded that the significant age dif-
ference observed in the uncorrected collagen content between of two 
groups may be due to the Hyp content of the elastin. Thus, when the 
non-collagen Hyp is subtracted from the total Hyp content of the tissues, 
the age difference previously observed in the uncorrected collagen con-
tent diminished, although a decreasing trend in the corrected collagen 
content with age is still observed. These results stress the necessity 
to correct for the non-collagen Hyp content in tissues which are rich in 
elastin, such as the aorta. 
Following the collagen determinations, the percent connective tis-
sue protein in the human aortas was calculated as previously described 
(Table 21). Again, a significant difference was observed between the two 
age groups, whether the uncorrected or corrected collagen content was 
used in the calculations. Using the corrected collagen content of the 
aortas, the mean percent connective tissue protein for the 2-17 year 
group was determined to be 76.9 ± 2.85%, while the mean percentage deter-
mined in the 34-90 year group was 57.5 ± 2.4%. Clearly, these results 
show a significant decrease (approximately 1/3) in the total connective 
tissue component of the aorta with age (p<O.OOl). This result is to be 
expected since this research has shown the elastin, and possibly, the 
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collagen content of the aorta decrease with age. 
Hydroxyproline Determination by Ion-Paired HPLC: 
During the development of the ion-paired HPLC method for the quanti-
tation of the desmosines, it was observed that standards of Hyp and Pro 
displayed k' values different from the other amino acids investigated 
(Table 14). From this finding, it was thought that it may be possible to 
simultaneously quantitate the Hyp and the desmosines in tissue hydroly-
sates, thereby yielding an estimate of both the elastin and collagen con-
tent from one analysis. However, it was found that that the mobile phase 
I 
which maximized the separation of the desmosines failed to sufficiently 
resolve Hyp and Pro in the tissue hydrolysates. 
In an attempt to separate Hyp from Pro and the other amino acids in 
the hydrolysate, the methanol percentage of the mobile phase was decrea-
sed to 19%. At this methanol percentage, Hyp was observed to completly 
separate from Pro (Fig. 25). The elution profile of the desmosines at 
this decreased methanol percentage, however, was such that they were un-
able to be quantitated, the peaks being very broad and unsymmetrical, due 
to the extended length of time on the column. 
It may still be possible to quantitate Hyp with the desmosines if a 
gradient elution technique is applied to the existing ion-paired HPLC 
method. With this system, the methanol percentage of the mobile phase 
would be gradually increased from 19% to 26% during the course of the 
analysis. Therefore, the Hyp, eluted at the lower methanol percentage, 
would separate from the other amino acids, and the desmosines, eluted at 
the higher methanol percentage, could still be quantitated. 
min 
0 
N" 0~ 
tn 
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Fig. 25. Chromatogram of Hyp and Pro separation by ion-
paired HPLC. Amino acid standards eluted with 
methanol/water (19/81, v/v), pH 3.0, containing 
0.01 mol/L heptane sulfonic acid. Amino acids 
detected at 205 nm. 
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CHAPTER 5 
DISCUSSION 
Elastin is one of the major connective tissue proteins of the body, 
and is unique in that it displays both elasticity and tensile strength. 
This protein has been implicated in several pathological conditions, in-
cluding atherosclerosis, emphysema, and a rare hereditary disease, pseu-
doxanthoma elasticum. Thus, it would be advantageous to determine the 
amount and composition of elastin in both 11 normal 11 and 11 pathological 11 
processes. However, this information is lacking in that the major source 
of data pertaining to the quantitation of elastin is derived from gravi-
metric determinations of the residue remaining following several extrac-
tion procedures. 
These extraction results have been shown to be non-reproducible when 
compared to both with-in and between method evaluations 14 ,24-26 . This 
variability of results has been partially explained by the glycoprotein 
content of the remaining residue, which is often defined as elastin. 
This glycoprotein content has been shown to vary considerably with the 
source and age of the tissue, and may be due to the method utilized to 
extract the various other proteins 46 ,86 . Also, these extraction methods 
are tedious, require several days for completion, and prone to methodo-
logical errors. 
Recently, a method for the estimation of elastin, which relies on 
the cross-linking amino acids Des and Ide, has been proposed 39 This 
method utilizes the quantitation of the two derived amino acids as an 
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index to the amount of elastin present in the tissue, just as the quanti-
tation of Hyp is frequently used as an index to the amount of collagen 
present 49• This inference is possible because Des and Ide have only 
been found in elastin and the non-elastin protein in egg shell membranes. 
This method of quantitation has several advantages over the extrac-
tion procedures. For one, after the tissue is dried and defatted, it is 
simply hydrolyzed in one step, which negates any errors associated with 
the possible loss of elastin by extraction procedures. Secondly, by its 
nature, the procedure is less tedious, and eliminates several methodo-
logical errors introduced by the extraction procedures. 
With this method, the desmosines are routinely quantitated by auto-
mated amino acid analysis. While this method of quantitation has been 
the accepted technique, there are disadvantages associated with the amino 
acid analyzers. For one, relatively few laboratories have a completely 
automated amino acid analyzer at their disposal, the instrument being. 
somewhat cost prohibitive. Secondly, amino acid analysis is a time con-
suming procedure, the average analysis requiring 3 to 6 hours. Finally, 
the limit of detectability for the desmosines with an amino acid analy-
zer, utilizing ninhydrin from detection, is at best 5 nmols, thereby 
limiting its use to tissues rich in elastin (aorta, lung) unless concen-
tration procedures are utilized. 
The results described in Chapter 4 show that an alternative method 
of quantitation of the desmosines is possible. This ion-paired HPLC 
method for the separation and quantitation of Des and Ide was shown not 
only to correlate well with the accepted method of quantitation, but to 
rival the amino acid analyzer in terms of general availability (not as 
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cost prohibitive), analysis time (less than 1 hour for complete analysis 
with no column regeneration), and sensitivity (lower limit of detection 
being approximately 100 pmol). 
This research has also shown that the estimation of the elastin con-
tent of canine aortic tissues, when calculated from the concentration of 
the desmosines, as opposed to determination by gravimetric procedures, 
were higher in 4 of the 5 samples studied. Yet due to one high gravimet-
ric result, the difference observed between the two methods was not sig-
nificant. This finding may be biased by the limited number of samples 
.investigated. The higher elastin content obtained by the HPLC method 
in the 4 samples mey be explained by sample degradation due to the harsh-
ness of the extraction procedures utilized in the gravimetric method 14 • 
24-26 The elastin results obtained by the quantitation of the desmo-
sines, when compared to those previously reported, were nund to be near-
ly identical 101 . 
When the elastin content of the canine aortas were combined with 
their respective collagen contents, it was observed that there was an in-
verse relationship between the two connective tisue proteins, and that 
the elastin plus collagen content of the canine aortas accounted for ap-
proximately 2/3 of their total FFDW. If, however, the non-collagen Hyp 
content of the aortas (elastin contains approximately 1.7% Hyp) was sub-
tracted from the total Hyp content, and the collagen determined using 
these corrected concentrations, a significant decrease of approximately 
10% was observed in the canine aortas. This is the first report of the 
overestimation of the collagen content in tissues rich in elastin. 
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hydrolysates (aortic arch region), it was observed that the elastin con-
tent varied according to the age of the individual. It was found that 
in the 11 human aorta samples studied, the highest elastin content oc-
curred in the first two decades of life, and decreased thereafter. These 
findings have been substantiated by others, though the absolute decrease 
varied between investigators, depending on the method utilized for the 
estimation of the elastin content 130- 132. 
The average elastin content of the human aortas was found to be 
somewhat less than those previously published 101 • This difference may be 
accounted for by the age dependence associated with the elastin content, 
and the sample population being skewed towards the aged. 
The collagen content of the human aortas were again shown to be in-
versly proportional to the elastin content, and this relationship was ob-
served to fall into the 2 age groups described for the elastin content 
(p=0.05). Also, a substantial decrease was noted in the collagen con-
tent of the human aortas when the non-collagen Hyp from elastin was sub-
tracted from the total Hyp content. 
There have been conflicting reports on the age dependence of the 
collagen content of human aortas, varying from a decrease with age to re-
ports of increases observed in the collagen content with age 133- 135 . 
These conflicting results may, in part, be explained by the non-collagen 
Hyp contribution of elastin. However, no definitive statement can be 
made in regard to the significance of the dependence of the collagen con-
tent with age from the results qescribed in Chapter 4. These findings, 
however, further emphasize the necessity for correcting for the Hyp con-
tent of elastin, in tissues rich in this protein. 
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Finally, the connective tissue protein content of the human aortas 
was determined to be approximately 2/3 the total FFDW, using the cor-
rected collagen content. This value is approximately 10% higher than 
those of a previous report 18 . However, the method of elastin and col-
lagen content utilized in that report involved extremely harsh extraction 
procedures, which could lead to sample degradation. 
As previously described in Chapter 4, an unknown peak appeared on 
the chromatograms of all the canine and human aorta hydrolysates. This 
peak was speculated to be lysinonorleucine, a minor cross-link found in 
elastin. With further observations, the relative peak height was found 
to increase with the age of the human aorta samples. If this peak is in 
fact lysinonorleucine, perhaps an inverse relationship may exist between 
it and the the desmosines. Thus with age, as the concentration of the 
desmosines decrease, the concentration of lysinonorleucine would in-
crease. This finding has been substantiated by other investigators 130 . 
This finding leads to a problem associated with the measurement of 
elastin by the quantitation of the desmosines, or any other amino acid. 
This problem is the question of possible changes in the absolute number 
of cross-links (Des, Ide, or lysinonorleucine) per unit elastin with 
time. There is some evidence that the Des and Ide cross-links in early 
fetal elastin is very low, and then increases in late fetal elastin 136 
Also, there is some evidence of a decrease in the number of Des and Ide 
cross-links per unit elastin in aged individuals 130 . If, in fact, this 
occurs, an argument can be made for a concomitant increase in the lysine-
norleucine cross-links, with a decrease in the number of Des and Ide 
cross-links. Assuming that the Des and Ide cross-links are required for 
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the elasticity and tensile strength displayed by the elastin molecule, a 
decrease in their absolute number, with a concomitant increase in the 
non-functional lysinonorleucine cross-links, may explain the "brittle-
ness" often associated with aging of the aorta. 
Yet, with these drawbacks, it may well be that the quantitation of 
the desmosines for their use as an index to the elastin content is as 
good as index as the others thus far suggested for postnatal measure-
ments. This would especially be true in dealing with tissues from a 
given species, of similar age. 
Recently, 3 other methods have been developed for the quantitation 
of the desmosines for use in the estimation of elastin 137-139 The 
first of these methods relies on the Hyp content of the tissue to deter-
mine both the elastin and collagen content 137 While, this method would 
offer simultaneous quantitation of the two connective tissue proteins, 
there are certain drawbacks associated with it. For one, since Hyp is 
contained in both elastin and collagen, each would be susceptible to con-
tamination from one another, thus tending to increase their amounts. 
Secondly, these methods rely on extraction procedures, whose problems 
have been previously described. Both of these problems can be eliminated 
if Des and Ide are utilized in place of the Hyp, since Des and Ide are 
specific markers for elastin, and their quantitation requires no extrac-
tion procedures. 
Another method recently developed employs an RIA for the quantita-
tion of desmosine 138 . Undoubtedly, this method would be more sensitive 
than any method previously described. However, this method is very de-
pendent on antibody production to desmosine, which has been shown to be 
a difficult procedure, by both the developers of the RIA method and in 
this research (Chapter 4). Also, the time of the assay is somewhat 
limiting, in that it requires a long equilibration procedure. 
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Finally, Faris and co-workers have reported using a HPLC system si-
milar to the ion-exchange method investigated during the course of this 
study, for the quantitation of the desmosines 139 Though their system 
fails to resolve Des from Ide, they claim to quantitate the total desmo-
sine concentration by detection at 275 nm. While this method may be 
useful as a preparative procedure, the absolute quantitation of the des-
mosines would be suspect for several reasons. For one, their method as-
sumes that the molar absorbance coefficients of Des and Ide are identi-
cal at 275 nm, however, their data fails to confirm this. Secondly, 
their method of quantitation assumes the Des to Ide ratio to be constant. 
This, however, was not shown in their report, in fact, the Des to Ide 
ratio has been shown to vary from tissue to tissue 101 , 121 - 123 It was 
for these reasons that the ion-exchange method was abandoned during the 
early HPLC investigations in this research. 
Therefore, the ion-paired HPLC method for the quantitation of the 
desmosines, and their subsequent use for the estimation of the elastin 
content, is clearly as good as, if not superior, to the methods previous-
ly described. Also, with further refinements (gradient elution), simul-
taneous quantitation of Hyp, Des, and Ide may be possible with the ion-
paired HPLC method. Thus the quantitation of these 3 amino acids from 
one analysis would yield an estimation of both the elastin and collaqen 
content, negating the use of a separate assay for Hyp. 
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APPENDIX A 
PREPARATION OF EHRLICH 1 S REAGENT: 
Solution A: 
138 
To 25 ml of cold absolute ethanol, 3.42 ml of concentrated sulfuric 
acid was slowly added. The mixture was kept cooled until needed. 
Solution B: 
To 25 ml of cold absolute ethanol, 15 g of para-dimethylaminobenz-
aldehyde was added and dissolved. 
Reagent: 
Solution A was slowly added to solution B (1:1) in an ice bath. 
The reagent was stable for 4 weeks if stored in a cold dark room. 
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